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ATPases associated with diverse cellular activities (AAA+) proteases in bacteria
help maintain protein homeostasis by degrading misfolded and regulatory
proteins. While a handful of protein targets for these proteases have been
identified in Caulobacter crescentus and other organisms, more research is
needed to elucidate mechanisms that govern substrate specificity. In the second
chapter of this thesis, I will elaborate on how AAA+ substrate specificity is less
rigid than previous work has suggested and how limiting ATP or mutations can
alter substrate preferences of the ClpXP protease. In the third chapter, I will
highlight our efforts to use a quantitative proteomics approach and how this
approach has provided us with insights on new phenotypes. The fourth chapter
of this thesis is a compilation of our efforts to identify suppressors of lon
defects. Lastly, the remainder of this thesis will present additional data that was
generated in the pursuit of these three projects and other endeavors.
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Chapter One

Introduction: Regulated Proteolysis in Bacteria

as written by Mahmoud SA and Chien P., published in Annual Reviews in
Biochemistry in 2018 (https://doi.org/10.1146/annurev-biochem-062917-012848)

Contributions: I wrote this review with Peter during my first official year in the
Chien lab. I did a deep literature search to write the text of the review, with edits
and suggestions from Peter. I also made most of the figures, with edits and
improvements made by Peter.

1.1 Abstract
Regulated proteolysis is a vital process that affects all living things. Bacteria use
energy-dependent AAA+ proteases to power degradation of misfolded and native
regulatory proteins. Given that proteolysis is an irreversible event, specificity and
selectivity in degrading substrates is key. Specificity is often augmented through
the use of adaptors that modify the inherent specificity of the proteolytic
machinery. Regulated protein degradation is intricately linked to quality control,
cell cycle progression, and physiological transitions. In this review, we highlight
recent work that has shed light on our understanding of regulated proteolysis in
bacteria. We discuss the role AAA+ proteases play during balanced growth as
well as how proteases are mobilized during changes in growth. We present
examples of how protease selectivity can be controlled in increasingly complex
ways. We promote the concept that coupling a core recognition determinant to
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one or more modifying agents is a general theme for regulated protein
degradation.

1.2 Introduction
Regulated protein degradation is a vital process that affects all biological
pathways. Because proteolysis is an irreversible event, the cell must take great
care to avoid degrading proteins indiscriminately. As a consequence, energydependent proteases are finely tuned cellular machines that recognize substrates
with exquisite sensitivity and selectivity.
In eukaryotes, proteins targeted for degradation are modified by the
covalent linkage of ubiquitin, a small protein that is appended to a lysine residue
on the target protein, for review see (1). Following additional extension by the
ubiquitin ligase families, the target protein is recognized and degraded by the
proteasome. In bacteria, regulated proteolysis is carried out by energydependent AAA+ (ATPases associated with cellular activities) proteases that use
the power of ATP hydrolysis to recognize, unfold, translocate, and degrade
substrates. Several energy-dependent proteases exist in bacteria: Lon, ClpXP,
ClpAP, ClpCP, ClpEP, HslUV, and FtsH (2–4). The importance of these AAA+
proteases is highlighted by the defects in viability and virulence of bacteria
deficient in one or more proteases (5, 6). For instance, bacteria lacking Lon are
known to be filamentous and more sensitive to ultraviolet radiation than their
wild-type counterparts (7). In the alpha-proteobacterium Caulobacter crescentus,
ClpXP is essential as mutants lacking this protease are arrested during the cell
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cycle (8). In the human pathogen Vibrio cholerae, Lon mutants were unable to
compete with wild-type V. cholerae in colonizing the infant mouse intestine (9).
AAA+ proteases share a similar general architecture being composed of
an ATPase and peptidase domain (10). In the case of Lon and FtsH, the two
domains are encoded on a single polypeptide chain (11, 12). On the other hand,
the Clp family of proteases encodes distinct hexameric ATPases, (either ClpA or
ClpX in gram-negative bacteria and ClpC or ClpE in gram-positive bacteria)
which associate with ClpP, a sequestered 14-subunit peptidase, to form ClpXP,
ClpAP, ClpCP, or ClpEP (2, 13). ClpP alone has the ability to degrade small
peptides, but in order to degrade larger, more stable substrates, ClpP must
associate with an unfoldase that harvests the energy of ATP hydrolysis to power
degradation (13, 14). This is separate from the properties of non-energy
dependent proteases and peptidases that serve important recycling roles in the
cell (15). The energy dependent AAA+ proteases will be the primary focus of this
review.

1.3 Operational Rules of Proteolysis
Regardless of architecture or function, bacterial AAA+ proteases seem to
follow similar operational rules. In the most general case, regulated proteolysis
requires recognition of an initial degradation determinant (also known as
degrons) followed by processive degradation of the polypeptide in an ATP
dependent manner (Figure 1.1). The unfolding power and processivity of an
AAA+ protease depends on both substrate and protease. For example, poorly
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folded substrates require less power to unfold (16). In addition, low complexity
portions of a substrate protein can stall proteases, resulting in release of partially
processed species (17, 18). By appending the same substrate with different
degrons, the unfolding and processivity of the known bacterial AAA+ proteases
classes were shown to vary over 2 orders of magnitude (19), with Lon being the
"worse" unfoldase and ClpAP being the "best". Because unfolding parameters
can vary wildly depending on the specific fold of the substrate, we are cautious in
generalizing these results to all substrates, but single molecule experiments have
recently shown similar correlations between some of these machines (20–22).
Due to the processive nature of these proteases, the most important
governing feature in vivo is likely the pioneering round of substrate engagement,
as once a substrate is committed for degradation it is unfolded and translocated
relatively quickly (22). This initial commitment is a combination of the specificity
of the protease for a given class of substrates and the ability of those substrates
to be recruited to the protease. In order for any AAA+ protease to successfully
degrade a substrate, there must be initial recognition of some determinant on the
substrate for the protease to start pulling on. This intrinsic recognition can be
modified through inhibition or activation by additional factors or the substrates
themselves in complex ways dependent on the need of the cell. These needs
can include quality control, as damaged or misfolded proteins must be cleared
before they elicit toxic effects. On the other hand, energy-dependent proteases
are also playing a major role in maintaining protein homeostasis during balanced
growth and during physiological transitions, such as stationary phase or
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sporulation. Although the mechanisms proteases employ for these distinct arms
of degradation may differ, the general theme of linking a core recognition
determinant to a modifier seems to be common.

1.4 Proteases as Quality Control Responders
Bacteria live in a dynamic, constantly fluctuating environment where they
are subject to proteotoxic stressors, such as heat or oxidative stress. Because
stress conditions require a swift response, regulated proteolysis allows bacteria
an effective way to get rid of damaged proteins rapidly, without having to wait for
protein removal by dilution through cell division (14, 23).
In addition, many stresses lead to the accumulation of misfolded proteins,
a problem that needs to be addressed by the cell before lethal consequences
ensue. The response to stress can be thought of as a competition between
rescuing factors, such as chaperones or repair enzymes, which seek to restore
proteins, and proteases, which seek to degrade them (Figure 1.2a). A central
challenge for the cell therefore lies in determining when a protein is terminally
damaged or misfolded and when rescue attempts should be abandoned for
proteolysis (24).

Recognizing failed quality products through specific tags: the ClpXP protease
Misfolded proteins are cleared by Lon in bacteria as well as in the
mitochondrial matrix in eukaryotes (25, 26). In Escherichia coli, Lon is thought to
be responsible for the degradation of approximately 50% of misfolded proteins
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(27), which suggests that the protease recognizes general motifs in misfolded
proteins with little sequence specificity. By contrast, the bacterial ClpXP
protease is far more selective and requires a specific degron sequence, such as
the ssrA tag, in order to recognize a substrate (28, 29). These two enzymes
exemplify different mechanisms used to ensure degradation of poor quality
proteins.
One of the best-studied examples in bacteria of regulated proteolysis is
the recognition of the ssrA tag by ClpXP following trans-translation, a mechanism
by which stalled ribosomes are rescued upon recruitment of tmRNA and nascent
polypeptides are tagged with the ssrA peptide (30). Because these stalled
ribosomes often arise from damaged messenger RNAs that lack a stop codon,
the resulting polypeptide products cannot be complete. Therefore, the presence
of the ssrA tag is itself the signal for a poor-quality protein. Recognition of the
ssrA tag by ClpXP is highly specific, with even a single amino acid substitution
abolishing substrate recognition (28). The amount of ssrA-tagged proteins is
staggering, with some estimates that an ssrA tag is appended in approximately 1
in every 20 translation events (31). During starvation ribosome stalling and
mRNA cleavage is enhanced, resulting in an even further taxing of the transtranslation system (32). Activation of certain endogenous toxins, such as MazF
and RelE, can induce rampant mRNA cleavage as well that is counteracted by
tmRNA (33). In these cases, the need for clearance of ssrA-tagged proteins
becomes even more urgent to eliminate the surge in truncated polypeptides.
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The ClpXP protease is fully capable of degrading ssrA-tagged proteins.
However, the adaptor protein SspB enhances the ability of ClpXP to recognize
and degrade ssrA-tagged substrates (34). SspB forms a homodimer, with each
subunit containing a substrate binding domain that binds ssrA-tagged proteins,
and a disordered C-terminal tail that interacts with ClpX. Efficient delivery of
ssrA-tagged substrates requires both tails on each subunit of SspB to interact
with ClpX, which tethers substrates to the protease to increase effective
substrate concentration (35). Thus, the ssrA tag is the fundamental protease
recognition determinant with the SspB adaptor acting as a modifier of this
recognition by serving as a passive tether (Figure 1.2b).
In addition to enhancing the ability of ClpXP to degrade ssrA-tagged
substrates, SspB also promotes degradation of N-RseA, the N-terminal fragment
of the stress response protein RseA (13, 36). During normal conditions, RseA
binds E, preventing it from activating transcription. However, during the
envelope-stress response, RseA is cleaved by proteases, freeing the N-terminal
segment of RseA in complex with E. SspB then delivers N-RseA to the ClpXP
protease, leaving E free to upregulate the envelope-stress response.
Remarkably, there is no clear sequence similarity between the region of N-RseA
that interacts with SspB and the region of the SsrA tag that binds SspB, indeed,
binding of N-RseA is in the opposite orientation as that of ssrA (36). Having a
single adaptor bind multiple substrates would enable a coordinated response
across several pathways and, perhaps not surprisingly, other examples of
adaptors enabling degradation of several substrates are now emerging (37–39).
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However, this multiplexing would eventually reach an upper limit as the need for
selectivity begins to outweigh the advantages of coordinated degradation.

Recognition of poor quality proteins without specific tagging: the Lon protease
The cellular response to an acute stress must often occur at timescales faster
than transcription and translation. Importantly, if the stress affects some of this
central machinery, such as the fidelity of the ribosome, then the consequences of
this stress must be repaired prior to restarting normal growth. It can be argued
that the Lon protease is uniquely suited to serve as a quality control protease due
to its ability to broadly recognize misfolded proteins and its ability to be
allosterically activated.
Quality control through regulated proteolysis requires bacteria to
discriminate between fatally misfolded or damaged proteins and proteins that
simply share features associated with compromised proteins, such as folding
intermediates or normal transient fluctuations in protein structures. Compared to
other energy dependent proteases, the Lon protease has the weakest unfolding
capacity (19), but a surprisingly promiscuous substrate repertoire. Indeed, Lon
seems to recognize hydrophobic residues on misfolded substrates that are
typically buried in the native structure as its primary recognition determinant
rather than any unique sequence motif (40) (Figure 2a) for review, see (41).
To properly survey protein quality, Lon must be able to distinguish
between fatally misfolded proteins and those that are in intermediate folding
states. Given that terminally misfolded proteins are kinetically trapped, it seems
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likely that the lifetime of the exposed hydrophobic regions may be a key
determinant for this type of quality control surveillance. The shorter lifetime of
exposed hydrophobic regions for a protein en route to the native state would set
the lower boundary of timescales where Lon should recognize a 'poor quality'
protein. By extension, this means that the Lon-substrate complex would need to
have sufficiently transient kinetics to be compatible with this discrimination,
otherwise, Lon would erroneously destroy proteins in the process of being folded
or fluctuating with normal dynamics. Thus, by combining a low efficiency
unfolding capacity with a broad recognition spectrum, the Lon protease gains
selectivity in recognizing truly misfolded proteins. A similar model is thought to
hold for eukaryotic quality control, where only persistent Hsp70 chaperone to a
folding client recruits the CHIP ubiquitin ligase to target the client for
ubiquitylation and degradation (42).
The ability of cells to use proteases and chaperones to ensure protein
quality can also apply to the quaternary structure of complex assemblies. For
example, individual subunits of protein complexes must be assembled in the
correct stoichiometry to ensure function. Overflow of these subunits could be
toxic, but AAA+ proteases are well-suited to destroy these unincorporated
subunits. For example, degradation of the CcdA antitoxin by the Lon protease is
inhibited when it is incorporated into the CcdAB complex (43) and degradation of
subunits are often suppressed when complexes are fully assembled. In this
respect, Lon is ensuring that active protein complexes maintain the proper
stoichiometry.
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Similarly, many protease substrates are DNA binding factors, including
transcription factors, replication regulators, and components of polymerases (44–
47). For some substrates, degradation is only evident when the substrate is not
binding DNA, suggesting again that a surveillance of the proper active complex
(in this case the degree of DNA-bound species) affords the cell the ability to
ensure destruction of proteins when they are not performing their function. We
caution that interpretation of this phenomenon is more complex as in some cases
DNA can stimulate substrate recognition by the protease (46), and in the case of
Lon, DNA can affect the protease directly (48, 49) and for review see (47).
The allosteric activation of Lon is an intriguing aspect to consider in light of
its role in quality control in the cell and its fundamental broad specificity. Many
enzymes exhibit substrate-activity relationships in line with the classic MichaelisMenten equation. The ClpXP and ClpAP proteases fall into this class, where
increasing substrate initially results in linear increases of degradation rates until
the enzyme becomes saturated and maximum reaction velocity (vmax) is
achieved (Figure 1.3a). In such cases, an underlying assumption is that the
enzyme specific activity is unchanged as substrate is added.
By contrast, the Lon protease has long been known to respond to
substrate concentration in a cooperative manner (50), with the working model
that substrates allosterically activate the Lon protease and increase its proteolytic
activity. Intriguingly it has been shown that substrates not only activate Lon for
their own degradation, but can also serve to activate Lon for degradation of other
substrates (51) . Thus, the behavior of Lon in the presence of two substrates
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could lead to regulation conducive to quality control. For example, suppose
substrate 1 has a higher affinity for Lon such that low concentrations of this
substrate are needed to allosterically activate Lon, while substrate 2 can only
activate Lon at a higher substrate concentration (Figure 1.3b-1.3c). Titration of
these substrates would show that at the same concentrations, substrate 2 is
degraded more slowly than 1. However, addition of substrate 1, even at
concentrations lower than substrate 2, would cause shifting of the Lon population
to the more active species resulting in more rapid degradation of substrate 2
(Figure 1.3d). Therefore, higher affinity substrates can effectively act as
activators of lower affinity substrate degradation. In these cases, the basic
recognition of the protease is modified by the presence of other substrates.
An intriguing extension of this biochemical framework is that it would result
in the greatest activation of the Lon protease when demand is greatest in vivo.
For example, during an acute proteotoxic stress, the rapid increase in misfolded
proteins would result in allosteric activation of Lon to eliminate these misfolded
proteins, but also to degrade fully active regulatory proteins as part of the stress
response. Such a case was recently reported in Caulobacter, with the Lon
dependent degradation of DnaA serving to halt cell cycle progression during
proteotoxic stress (52). This type of regulation would also make sense for a
protease such as Lon given its ability to recognize features found in all proteins
(such as hydrophobic residues), as persistently high activation of Lon would
inevitably result in the destruction of proteins not needed for quality control.
Indeed overproduction of Lon in E. coli results in cell death, in part because of
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rampant degradation of antitoxin proteins (53). Finally, because Lon can be
allosterically regulated by non-protein molecules such as DNA, it is tempting to
speculate that a surge in Lon activity upon allosteric activation could also be
deployed under additional stress responses, such as during genotoxic stress
where extended exposure of single-stranded DNA is a unique flag for DNA
damage.

1.5 Regulated proteolysis during balanced growth
Coordinating proteolysis with cell division and replication
The cell cycle involves a highly regulated sequence of events in which DNA is
faithfully replicated and divided into daughter cells. Progression through the cellcycle requires regulated proteolysis to ensure the timely degradation of
regulatory proteins necessary to drive this irreversible process. In eukaryotes, the
concerted activity of APC/C and SCF ubiquitin ligases enforce the selective
tagging and ultimate degradation of many regulatory factors (54).
In Caulobacter crescentus, asymmetric cell division yields a motile,
flagellated swarmer cell and a sessile stalked cell (23, 55). The stalked cell is
replication-competent and can immediately commence DNA replication and enter
the cell cycle. However, the swarmer cell must first shed its flagellum and grow a
stalk before it can initiate chromosome replication. Thus, the swarmer to stalked
transition, also known G1 to S transition, is coupled to DNA replication and is
intricately linked to regulated protein degradation (56). At the center of this
transition is the essential master regulator, CtrA which is responsible for
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regulating expression of approximately 100 genes (57–59). CtrA also binds to
and inhibits the origin of replication in swarmer cells, preventing swarmer cells
from initiating replication. Therefore, when it becomes time to resume DNA
replication during the swarmer-to-stalked transition, CtrA must be eliminated.
This occurs through dephosphorylation by the CckA pathway (60–62) and
proteolysis by the ClpXP protease (8, 63).
Since the levels of ClpXP remain constant during the cell-cycle, additional
mechanisms must exist to support the cyclic oscillations seen in CtrA levels
during the cell cycle (8). Indeed, a tightly regulated series of events, involving
the adaptor proteins CpdR, RcdA, PopA, and the second messenger cyclic diGMP ensures the degradation of CtrA (and other substrates) and timely entrance
into S phase (64).
Intriguingly, although CtrA degradation in vivo requires ClpXP as well as
additional accessory factors, ClpXP can degrade CtrA without these adaptors in
vitro (65, 66). This paradox was reconciled by data that showed that CpdR,
RcdA, PopA can increase the rate of CtrA degradation in vitro as the addition of
these factors lowered the Km 10-fold, keeping Vmax constant (66). Intriguingly, the
assembly of the adaptors was shown to be essential during times when
recognition of CtrA by ClpXP was less robust, such as when CtrA is bound to
DNA and thereby inaccessible (67). This ensures that there is complete removal
of CtrA to allow resumption of DNA synthesis as even a small amount of CtrA is
enough to inhibit the origins of replication (66, 68).
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Regulated protein degradation is linked to cell-cycle progression in other
bacteria as well. In E. coli, FtsZ is an essential component of the cell division
machinery. FtsZ polymerization is necessary to form the z-ring, the site where
septation and cell division occurs. Studies in Bacillus subtilis determined that
ClpX inhibits FtsZ polymerization in a Clp and ATP-independent manner (69).
However, in E. coli ClpXP has been shown to degrade FtsZ directly, potentially
functioning to promote the disassembly of FtsZ polymers (70, 71). Similarly, both
ClpAP and ClpXP can degrade Caulobacter FtsZ in vitro as well as in vivo (72).

Diversifying proteolysis through hierarchies
Recently, CpdR, PopA, and RcdA have been shown to function as adaptors
capable of degrading various classes of substrates in a hierarchical manner in
Caulobacter (38) (Figure 1.4). The lowest level of the hierarchy consists of
ClpXP alone, which can theoretically degrade many substrates limited only by
the recognition determinants of those substrates. For example, trapping studies
in E. coli and Caulobacter have identified hundreds of potential substrates,
several of which are degraded by ClpXP alone in vitro (29, 73) and proteomic
studies in Staphylococcus aureus illustrate the range of substrate degraded by
the Clp family (74). The next tier consists of ClpXP and the adaptor CpdR. While
traditional adaptors can bind their substrates directly, two-hybrid studies found
that CpdR alone does not interact with its substrates strongly (37). Instead, CpdR
primes ClpXP by binding to the N-terminal domain of the unfoldase domain,
preparing ClpXP to engage its first class of substrates, which include McpA, a
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chemoreceptor (62), and the cyclic di-GMP phosphodiesterase PdeA (37, 75).
This priming event opens ClpXP to an array of adaptors and substrates that
would have been inaccessible before such as RcdA, which binds a CpdR-primed
ClpX directly to establish the third tier of the hierarchy. In this way, RcdA acts
like a canonical adaptor in tethering cargo to ClpXP to enhance delivery of a
second class of substrates, including the developmental regulator TacA and
various proteins of unknown function (38).
The pinnacle of the hierarchy requires the addition of the adaptor PopA
bound to cyclic di-GMP, which culminates in the degradation of CtrA (38, 66, 76)
and likely other substrates such as GdhZ and KidO (77, 78). Strikingly, bacterial
two-hybrid experiments demonstrated that PopA alleles which cannot engage
cyclic di-GMP still bind RcdA (38, 76). This suggests that even in the absence of
delivery, PopA can compete with the RcdA-dependent degradation of substrates
like TacA, suggesting that members of the hierarchy can act as both adaptors
and anti-adaptors (38, 56). Cross species comparisons find that CpdR and RcdA
are highly conserved in all alpha proteobacteria, but the presence of PopA is
more restricted (79), leading to the speculation that CpdR/RcdA represent a
more ancient aspect of this adaptor hierarchy. Interestingly, RcdA is essential in
Agrobacterium tumefaciens (80) , suggesting that this adaptor hierarchy might be
more deeply woven into the essential physiology of other bacteria.

The costs and benefits of adaptors.
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Balanced growth requires regular predictable changes in protein levels to drive
replication and division. Although AAA+ proteases can have different ranges of
selectivity, there is a clear need to augment their specificity through other
regulators. Adaptor proteins in their most basic form can be thought of as simple
tethers that locally increase the concentration of potential protease substrates.
However, there is a conflict in that adaptors which bind cargo weakly may not
efficiently deliver substrates to the protease while adaptors that grip cargo too
tightly could also hinder the substrate degradation by the protease. Therefore,
there must be an appropriate tuning of the lifetimes of the different subcomplexes
involved in adaptor-dependent handoff to ensure robust degradation. Below, we
illustrate how the well-characterized SspB/ssrA system demonstrates this
principle.
As described previously, the SspB adaptor binds ssrA-tagged substrates
and delivers them to the ClpXP protease. Bulk measurements find that GFP
tagged with ssrA binds SspB with a kon of ~ 5 µM-1s-1 at 30C and a KD of ~ 50
nM yielding a ~4 second lifetime for this complex (81) (Figure 1.5). Singleturnover experiments suggest that the limiting step for degradation by ClpXP is
substrate commitment, rather than translocation or proteolysis, with an estimate
of ~30 seconds for tagged GFP at saturating concentrations (82) . Therefore,
cargo can be released from the adaptor's grip 7-8 times during the time that
ClpXP is establishing commitment. However, if a cargo binds SspB 10-fold more
tightly, with the same on rate, then this new 40 second lifetime exceeds the
ClpXP commitment time and may result in paradoxically slower proteolysis.
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Although such substrates have not yet been identified, this simple example
illustrates the point that tighter binding of an adaptor to cargo may not result in
more robust delivery to the protease and that an optimum balance likely exists
between adaptor-cargo lifetimes and protease commitment timescales.
Adaptors can also serve as more than tethers. In addition to anchoring
cargo to the protease, adaptor binding may also cause degrons in the cargo
protein to be exposed, as described for YjbH/Spx (83) and RssB/RpoS (84, 85).
Adaptors could also affect the protease itself. As described above, CpdR binds
to ClpX and activates the ClpXP protease for degradation of the substrate PdeA,
but CpdR on its own fails to bind PdeA (37). Binding of CpdR, or similar
adaptors, may contribute to substrate engagement directly, e.g., providing
additional low affinity contacts, or may affect ClpXP substrate engagement
through allosteric changes of ClpX itself. Given our discussion above regarding
the balance of protease commitment and adaptor-cargo lifetimes, it is tempting to
consider that some adaptors may influence protease specificity through altering
the commitment time of the protease rather than changing its ability to directly
recognize a target.

Regulated proteolysis during changes in growth phase
Bacteria are constantly being challenged in their environments with changing
conditions, such as nutrient deprivation, that necessitate a swift response.
Regulated proteolysis is required for bacteria to undergo the necessary
physiological transitions and adaptation needed for survival and persistence. An
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example of this is the transition from logarithmic growth to stationary phase,
when growth slows and cells alter their metabolism to accommodate this change
in phase (86). This transition requires S, also known as RpoS, an alternative
sigma factor that can compete with 70 during stationary phase to significantly
alter gene expression profiles. During logarithmic growth, RpoS is rapidly
degraded to undetectable levels by ClpXP with the required assistance of the
adaptor RssB (85, 87) (Figure 1.6a).
During entry to stationary phase, RpoS becomes stabilized and produces
a surge in transcription of RpoS regulated genes (88, 89). Inhibition of RssB
activity is accomplished by a group of anti-adaptors, each specific for a particular
stress response. In E. coli, three anti-adaptors have been identified, IraP
(Inhibitor of RssB activity during phosphate starvation), IraD (Inhibitor of RssB
activity during DNA damage), and IraM (Inhibitor of RssB activity during
magnesium starvation). Interestingly, each anti-adaptor binds to RssB in a
different binding mode (2, 90, 91). IraP binds at the C-terminal domain of RssB
while IraD interacts with the N-terminal domain, and IraM has been shown to
make interactions with both domains. This example shows how a family of
distinct anti-adaptors, each binding at a characteristic location, can each prevent
the degradation of RpoS, allowing the cell to mount a rapid universal program in
response to a variety of stresses.
In nutrient-poor conditions, Bacillus subtilis initiates a sporulation program
resulting in mature spores that can withstand harsh environmental conditions.
The structural protein SpoIVA is required for proper assembly of the spore
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envelope. To ensure the fidelity of the sporulation program, Bacillus relies on
regulated proteolysis as a quality control mechanism to remove spore envelopes
that have been improperly assembled (92) (Figure 1.6b). In sporulation defective
cells, CmpA, an adaptor, delivers SpoIVA to ClpXP for degradation, ultimately
leading to the lysis and removal of the defective cell from the population.
However, in cells that properly constructed the spore envelope, CmpA is
degraded, preventing the degradation of SpoIVA and allowing cells to continue
the process of sporulation.
Bacteria growing in a liquid environment use flagella to swim in threedimensional space. When shifted to solid media, bacteria transition their mode of
motility from swimming to swarming. In Bacillus subtilis, this transition requires
Lon-dependent degradation of SwrA, a master regulator of flagellar biosynthesis
(93) (Figure 1.6c). When Bacillus is in a liquid environment, Lon robustly
degrades SwrA in the presence of SmiA, a Lon-specific adaptor protein. Lon was
unable to degrade SwrA both in vivo as well as in vitro in the absence of SmiA.
When Bacillus transitions to a solid surface, Lon-mediated degradation is
inhibited via an unknown mechanism and SwrA levels increase, resulting in
increased flagellar density which is necessary for swarming motility. Intriguingly,
SmiA was the first Lon-specific adaptor to be discovered, but more recent work
using a Lon trapping approach has led to the discovery of HspQ, a conserved,
small heat shock protein, that can also enhance Lon-dependent degradation of
known substrates in the gram-negative bacterium Yersinia pestis (39).
Understanding how Lon activity can be controlled in so many different ways and
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the consequences of this regulation is an outstanding question clearly worth
exploring.

Proteolytic responses in response to starvation
Amino acids are the building blocks of proteins and all organisms must be able to
accurately assess amino acid levels to avoid costly interruptions in protein
synthesis (94). In times of amino acid starvation, protein degradation could
replenish amino acid pools. In eukaryotes, inhibition of the ubiquitin-proteasome
system results in a lethal depletion of amino acid pools which could be rescued
by externally supplementing with additional amino acids or reducing translation
(95). Earlier studies in E. coli found that starvation causes an increase in protein
degradation which mirrored the rate of synthesis of new proteins (96). However,
very little is currently known about how starvation mechanistically leads to amino
acid recycling in bacteria.
In bacteria amino acid starvation leads to increased cellular levels of the
alarmone (p)ppGpp , eliciting what is known as the stringent response (97).
Increased levels of (p)ppGpp lead to many downstream effects, effectively
allowing the cell to divert resources away from translation and towards amino
acid biosynthesis (98). One of the effects of (p)ppGpp accumulation is the
inhibition of the enzymes that break down polyphosphate, leading to increased
polyphosphate levels (99). Work from Kornberg and colleagues have shown that
polyphosphate can stimulate the proteolysis of ribosome subunits and other
proteins by the Lon protease (100–102). This has led to the provocative
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hypothesis that during amino acid stress, activation of the Lon protease via
ppGpp/polyphosphate induction will reduce ribosome pools to slow down
translation and replenish pools of amino acids. Although recent work suggests
that polyphosphate activation of Lon proteolysis may not be a universal feature
for all substrates (103) , the ability of regulated proteases such as Lon to
contribute to nutrient stress responses to improve survival under starvation
conditions is a very appealing notion. Indeed, prior work has shown that loss of
energy dependent proteases in bacteria yields compromised responses to
starvation (104, 105).

1.6 Perspective
Energy dependent proteases can differ dramatically in architecture and substrate
preference. However, a recurring theme is that regulated proteolysis requires
two elements for robust controlled substrate degradation. All substrates must
contain some type of recognition determinant that can be engaged by the
protease in order to begin unfolding and processing. This determinant can be
highly sequence dependent, as in the case of ssrA and ClpXP, or it can be more
general, as seen with recognition of hydrophobic residues by Lon. To truly
maintain regulation, these determinants are further elaborated by modifying
factors such as adaptors that deliver substrates directly or prime the protease for
substrate recognition. These modifiers can also be a property of the protein
itself, e.g., protein dynamics that cause transient or extended display of residues
normally in the hydrophobic core. Finally, substrates themselves can act as
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modifiers to alter the specific activity of a protease in an effort to mount an
effective stress response.
From a therapeutic perspective, physiological consequences of protease
loss are especially apparent during stressful situations, such as when pathogens
invade their hosts. Therefore, these proteases would be opportune targets to
explore for the development of future antibiotics. Indeed, recent studies have
shown that small molecule inhibitors of both Clp and Lon family proteases can be
highly efficacious for various bacteria (106–108). Perhaps most intriguingly is the
fact that unconstrained activation of these proteases could be as toxic to the
bacteria (or more so) than inhibition. As a recent illustration of this possibility, the
ClpP activating acyldepsipeptide ADEP was able to eradicate Staphylococcus
aureus even in conditions where the cells were tolerant of other antibiotics (109).
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Figure 1.1 Energy-dependent proteases are composed of an ATP-hydrolysis
active unfoldase domain and a chambered peptidase domain. Through
successive rounds of ATP hydrolysis, a specific substrate protein is selected by
the protease, unfolded by the ATPase domain, and translocated through a
central pore to the peptidase chamber where it is degraded.
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Figure 1.2 Proteases can survey protein quality in the cell. (a) Competition
between chaperones and proteases dictates the fate of proteins. Proteases, such
as Lon, must be able to distinguish between normal protein dynamics with
transient excursions into non-native states and terminally misfolded proteins that
must be degraded before forming toxic aggregates. Lon recognizes hydrophobic
motifs ( yellow circles) that are usually buried in the core of a native protein.
These motifs are exposed more persistently for misfolded proteins than during
the transient fluctuations of properly folded proteins, allowing Lon to recognize
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and degrade the terminally misfolded proteins. Chaperones contribute to this flux
by binding misfolded proteins in an effort to refold them. (b) Following the
process of trans-translation, in which an ssrA tag is appended to incomplete
polypeptides, the adaptor SspB binds tagged substrates and tethers them to
ClpXP, enhancing the protease’s ability to degrade these substrates.
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Figure 1.3 Lon is subject to allosteric regulation. (a) Many proteases, such as
ClpXP and ClpAP, adhere to typical Michaelis-Menten kinetics, and adding
increasing amounts of substrate will increase the rates of degradation until the
protease becomes saturated and Vmax is reached, resulting in the classic
hyperbolic curve. This contrasts with Lon, which exhibits positive cooperativity
upon increasing substrate concentration. The working model is that Lon exists in
low (red protease) and high ( green protease) activity states with substrate
binding promoting the highly active state. (b) In the case of substrate 1, which
binds Lon poorly, activation requires much higher concentrations of the substrate
to shift Lon to the active state. (c) Substrate 2 has a strong affinity for Lon, and
relatively low amounts of substrate are needed for activation. (d ) If the
concentration of substrate 1 is kept the same and the high-affinity substrate 2 is
added, Lon will be shifted to the active form, leading to robust degradation of the
normally poorly degraded substrate 1.
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Figure 1.4 Adaptors assemble in a hierarchical manner to degrade various
classes of substrates. ClpXP can degrade numerous substrates on its own,
including ssrA-tagged proteins. During the G1-to-S transition in Caulobacter
crescentus, the adaptor CpdR first primes ClpXP, allowing it to recruit the first
class of substrates (PdeA, McpA, etc.) for degradation. The primed protease can
now recruit another adaptor, RcdA, to degrade a second class of substrates,
such as the transcription factor TacA and others. Finally, the adaptor PopA binds
RcdA and in the presence of the second messenger cyclic di-GMP completes the
hierarchy to deliver a third class of substrates, including the master regulator
CtrA, to ClpXP. As the hierarchy is assembled and adaptors are added onto the
protease, specificity increases. When ClpXP is limited, this increase in specificity
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also comes at the cost of preventing degradation of other members of the
substrate pool.

Figure 1.5 Substrate degradation by ClpXP is rate-limited by the commitment
step, where the protease initially engages a target, rather than the unfolding or
translocation steps, which are relatively fast. Commitment is estimated to be ∼30
s for degradation of tagged GFP by ClpXP (82). Tethering adaptors (such as
SspB and RcdA) enhance degradation of substrate, but the strength of the
interaction between the adaptor and substrate must be tuned to the commitment
time for the protease (ii ). Poor adaptor-cargo binding results in failure to deliver (i
), but binding too tightly (iii ) hinders substrate release during the commitment
step for protease engagement of the substrate.
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Figure 1.6 Regulated proteolysis is required during physiological transitions and
changes in growth. (a) When bacteria are actively growing in logarithmic phase,
ClpXP rapidly degrades the alternative sigma factor RpoS in an RssB-mediated
manner. When RssB is phosphorylated, it has high affinity for RpoS and can
deliver it to ClpXP for degradation. Anti-adaptors bind to RssB in different binding
modes that depend on the kind of stress the bacteria encounters, preventing it
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from delivering RpoS for degradation. (b) Bacillus subtilis requires proteolysis by
ClpXP to ensure proper spore envelope assembly. In cells with improperly
assembled envelopes, the adaptor CmpA delivers SpoIVA to ClpXP for
degradation, leading to lysis of the defective cell. If the spore envelope is
properly assembled, the adaptor is targeted for degradation by ClpXP instead. (c)
Lon-mediated degradation is required for proper motility during the transition from
liquid to solid media. In liquid media, Lon degrades SwrA with the help of SmiA,
an adaptor protein. Upon shift to solid media, degradation of SwrA is inhibited,
leading to an increase in SwrA levels necessary for swarming on solid media.
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2.1 Summary
In bacteria, AAA+ proteases such as Lon and ClpXP degrade substrates with
exquisite specificity to promote normal growth and stress responses. Here, we
show that a mutation in the ATP binding site of ClpX shifts protease specificity to
promote degradation of normally Lon-restricted substrates, suppressing much of
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the pleiotropic defects of a strain lacking Lon. However, this ClpX mutant is
worse at degrading normal ClpXP targets, suggesting an optimal balance in
substrate preference for a given protease that is surprisingly easy to alter.
Reconstitution with purified proteins shows that these effects are due to changes
in recognition and processing of substrates directly. We find that wildtype ClpXP
specificity can be similarly altered when ATP is limited, which paradoxically
increases degradation of some substrates. This activation corresponds to
changes in ClpX conformation, leading to a model where ClpX cycles between
'open' and 'closed' states in an ATP-dependent manner. Limiting ATP or
mutation can alter the conversion between states to yield better recognition of
unorthodox substrates but worse recognition of native targets specifically bound
by the closed state. Based on current structures of these unfoldases, we
propose that other AAA+ unfoldases operate under similar ATP-dependent
specificity principles.

2.2 Highlights
•

A mutation in the Walker B region of ClpX induces recognition of new
substrates.

•

Proteases are optimized for specific functions but barrier to recognize new
substrates is easily overcome.

•

Expanding substrate recognition by a protease comes at the cost of
reducing native substrate degradation.
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•

Decreasing ATP enhances ClpXP mediated degradation of certain classes
of substrates.

•

ClpX adopts distinct conformational states to favor better recognition of
some substrates over others.

2.3 Introduction
Energy-dependent protein degradation regulates normal growth and
stress responses in all cells. In bacteria, regulated proteolysis is carried out by
several energy-dependent AAA+ (ATPases associated with cellular activities)
proteases which include Lon, ClpXP, ClpAP, HslUV, FtsH (Gur et al., 2011;
Mahmoud and Chien, 2018). These proteases share a similar general
architecture containing an unfoldase domain and a non-specific peptidase (Sauer
and Baker, 2011). The two domains can be encoded on a single polypeptide,
such as in the case of Lon and FtsH, or they can be encoded by separate
proteins, an ATPase, such as ClpX, and a peptidase, such as ClpP (Baker and
Sauer, 2012; Langklotz et al., 2012; Lee and Suzuki, 2008). Using the power of
ATP hydrolysis, the unfoldase recognizes, unfolds, and translocates substrates
into the sequestered peptidase chamber to be degraded. Because they are
critical for maintaining proteostasis, loss of these proteases results in defects in
growth, cell-cycle progression, stress responses, and pathogenesis
(Breidenstein et al., 2012; Howard-Flanders et al., 1964; Jenal and Fuchs, 1998;
Rogers et al., 2016).
Despite the similarities in both architecture and mechanism, these
proteases generally have distinct niches of substrate preference. For example, in
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Caulobacter crescentus, Lon is the principal protease for degradation of the
replication initiator DnaA (Jonas et al., 2013), the methyltransferase CcrM
(Wright et al., 1996), and the transcriptional regulator SciP (Gora et al., 2013). By
contrast, the ClpXP protease degrades cell-cycle factors like CtrA and TacA
during cell-cycle progression through an adaptor hierarchy (Joshi et al., 2015).
Lon is also responsible for misfolded protein degradation (Goldberg, 1972; Gur
and Sauer, 2008; Jonas et al., 2013). However, while a handful of target
substrates for these AAA+ have been identified, it remains unclear how
proteases are able to discriminate among protein targets and recognize distinct
substrates for irreversible degradation.
In this work, we find that a variant of ClpX (clpX*) can compensate for the
absence of the Lon protease. Expression of clpX* suppresses defects in motility,
growth, filamentation, and sensitivity to stress normally seen in a ∆lon strain. In
addition to this phenotypic rescue, degradation of normal Lon substrates is
restored in vivo and in vitro by ClpX*P. This increased ability to degrade
noncanonical substrates comes at the cost of reduced degradation of ClpXPspecific substrates, resulting in fitness defects in otherwise wildtype strains
expressing the clpX* allele. Further mechanistic characterization shows that
ClpX* has reduced catalytic efficiency for ATP hydrolysis, suggesting a
connection between ATP utilization and substrate specificity. Consistent with this,
limiting ATP for wildtype ClpXP shifts substrate preferences to that of ClpX*P.
Limited proteolysis, differential scanning fluorimetry (DSF), and Hydrogendeuterium exchange mass spectrometry (HDX-MS) show that the ClpX unfoldase
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adopts distinct conformations under these ATP limiting or saturating conditions.
Taken together, our work demonstrates that ATP-dependent dynamics between
conformational states are important for substrate recognition by AAA+
unfoldases.
2.4 Results
2.4.1 A suppressor screen identifies a clpX mutant which rescues Δlon
We reasoned that a suppressor screen would allow us to identify novel
Lon-related interactions and used a transposon library to identify mutations that
restore motility to a Δlon strain. We isolated a high motility mutant with a
transposon insertion in CCNA_00264; however, transduction experiments
revealed that this transposon alone was not able to rescue motility (Figure S1A).
Sequencing the genome of the suppressor strain showed a point mutation in
clpX, which resulted in a single amino acid change from glycine 178 to alanine
(clpX*). This glycine is highly conserved among ClpX homologs and immediately
adjacent to the Walker B motif (Figure S1C). By generating the clpX* allele in a
Δlon background, we found that clpX* on its own partially restores motility (Figure
1A).
We were intrigued that a single mutation in clpX could restore motility to
cells lacking Lon and chose to further characterize this strain. Cells lacking Lon
show growth defects that exhibit as an extended lag phase and reduced cell
mass accumulation in stationary phase (Figure 1A). The clpX* allele rescues the
mass accumulation defect, but not the extended lag (Figure 1A). Δlon strains
also have significant morphological deficiencies including elongated cell length
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and longer stalks, external polar organelles characteristic of Caulobacter. We
found that the clpX* mutant restored the cell length of ∆lon strains to near
wildtype levels (Figure 1B, 1C). However, stalks remained elongated in the Δlon
clpX* strain (Figure 1B, 1C).
We next wondered if, in addition to suppression of Δlon morphological and
growth defects, sensitivity to certain stressors would be suppressed by this clpX*
allele. One of the originally described phenotypes for E. coli lon mutants is DNA
damage sensitivity (Mizusawa and Gottesman, 1983; Witkin, 1946) and
Caulobacter lon strains are also highly sensitive to various DNA damaging
agents (Zeinert et al., 2018), including mitomycin C (MMC) (Figure 1C). We
found that ∆lon clpX* was 100-fold more resistant to MMC than Δlon alone
(Figure 1C).
As mentioned previously, Lon is the major protease responsible for the
degradation of the replication initiator DnaA and Δlon strains accumulate excess
chromosome content (Jonas et al., 2013; Wright et al., 1996). Like the
morphological abnormalities, overreplication is suppressed in the ∆lon clpX*
strain which shows similar chromosome content as wildtype cells (Figure 1D,
S1D). To determine if this rescue extended to a systems-level correction, we
compared RNA-seq profiles of wildtype, ∆lon and ∆lon clpX* strains. As
expected, many genes (435) are differentially expressed upon loss of Lon (Figure
1E), while the ∆lon clpX* strain shows fewer differences (119) with only 85 genes
overlapping between these sets. Finally, we assayed the overall physiological
consequence of ClpX* using competitive fitness in mixed cultures. We grew
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cultures of ∆lon or the ∆lon clpX* strain together with ∆lon strains constitutively
expressing the Venus fluorescent protein (Persat et al., 2014). We found that
∆lon clpX* cells were more fit than ∆lon cells (Figure S1E). Our interpretation is
that expression of clpX* in a ∆lon background largely shifts the phenotypes and
transcriptional landscape to more wildtype profiles.

2.4.2 ClpX* restores degradation of Lon substrates in vivo
Because cells lacking Lon would accumulate normally degraded
substrates, we hypothesized that the rescue we observed in the Δlon clpX* strain
was likely due to lower levels of Lon substrates, such as DnaA, CcrM, and SciP
(Figure 2A) (Wright et al., 1996; Gora et al., 2013; Jonas et al., 2013). As
expected, in unsynchronized cells, DnaA and CcrM levels are higher in the ∆lon
strain than in wildtype (Figure 2B). Similarly, SciP levels are higher in ∆lon
swarmer cells in comparison to wildtype (Figure 2D). Interestingly, levels of
DnaA and SciP are restored to wildtype levels in the ∆lon clpX* strain; however,
CcrM remained at higher levels (Figure 2B). The reduced levels of DnaA likely
explain the rescue of replication defects and enrichment analysis of the RNA-seq
results shows that the SciP-controlled regulon and cell-cycle gene expression are
largely restored in the ∆lon clpX* strain (Figure S2). We reasoned that
expression of clpX* rescues normal growth and critical stress responses in a ∆lon
strain through restoring wildtype levels of key proteins.
Next, we explored the mechanism by which a mutation in ClpX is able to
restore steady state levels of DnaA and SciP. Because DnaA and SciP are

51

controlled by proteolysis, we suspected that protein turnover may be affected.
As expected, DnaA is largely stabilized in ∆lon strains (Figure 2C; Jonas, et al.
2013); however, we found that DnaA degradation was restored in the ∆lon clpX*
strain, with a half-life similar to that of wildtype (Figure 2D). SciP protein
dynamics and cell-cycle phase specific levels were also restored in ∆lon clpX*
cells (Figure 2D). By contrast, CcrM degradation was still solely dependent on
Lon, even when clpX* was present, in both unsynchronized cells (Figure 2C) and
during cell-cycle progression (Figure S3A).

We considered that changes in protein turnover could be either due to a
gain-of-function in the clpX* mutant or by indirect cellular effects associated with
a loss-of-function in clpX. To test this, we created a merodiploid Δlon strain
expressing a second copy of clpX or clpX* under control of the native promoter
along with a normal chromosomal copy of clpX. We reasoned that if the effect
was direct, then expression of clpX* would be sufficient to restore DnaA
degradation. If the effect was indirect, then DnaA would remain stable.
Consistent with a gain-of-function phenotype for the clpX* allele, we found that
DnaA turnover increased upon expression of clpX* but not wildtype clpX (Figure
2E). Similarly, the phenotypic rescue we observed in the Δlon clpX* strain was
also due to a gain-of-function activity as the merodiploid strain expressing clpX*
suppressed Δlon defects, such as growth, motility, and genotoxic stress
tolerance (Figure S3B-D). Because ClpXP is a AAA+ protease, we hypothesized
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that ClpX*P (the protease complex of the variant ClpX* with wildtype ClpP) was
now able to recognize and degrade substrates normally degraded by Lon.

2.4.3 ClpX*P directly degrades Lon substrates in vitro
As a direct test of our hypothesis, we purified the ClpX* variant and
reconstituted degradation in vitro. Upon initial characterization of purified ClpX*,
we found that it formed an active ATPase, but hydrolyzed ATP three times faster
than wildtype (Figure S4A). Consistent with the fact that Lon is the principal
protease for DnaA degradation (Jonas et al., 2013; Liu et al., 2016), we found
that wildtype ClpXP poorly degraded DnaA in vitro (Figure 3A). However,
purified ClpX*P could degrade DnaA four-fold faster than ClpXP (Figure 3A).
Similarly, SciP was degraded three-fold faster by ClpX*P in comparison to ClpXP
(Figure 3A). Finally, as predicted from our in vivo results, CcrM was not degraded
by either ClpX*P or ClpXP (Figure 3A, Figure S4B), but was well degraded by
Lon (Figure S4B). Thus, ClpX* appears to have an expanded substrate profile
which includes some Lon substrates, but others, such as CcrM, remain exclusive
to Lon.
Lon recognizes exposed hydrophobic amino acids (Gur and Sauer, 2008)
and is best known as a quality control protease that eliminates mis/unfolded
proteins (Goff et al., 1984). Given its altered specificity, we considered if ClpX*
could now recognize these substrates. Casein is commonly used as an in vitro
model substrate for mis/unfolded proteins. Lon robustly degrades fluorescently
labeled casein, whereas wildtype ClpXP poorly degrades this substrate (Figure
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3B). Intriguingly, ClpX*P degrades FITC-casein more than twice as fast as ClpXP
(Figure 3B, Figure S4C). Similar to casein, ClpX*P degrades another unfolded
Lon substrate, a chemically denatured domain of titin tagged with the
hydrophobic sequence β20, better than wildtype ClpXP (Figure S4D).
Because cells lacking Lon are sensitive to proteotoxic stresses that create
misfolded proteins and because ClpX*P is better at degrading mis/unfolded
substrates than wildtype ClpXP, we wondered if the ∆lon clpX* strain would be
more resistant to stressors that induce cellular protein misfolding. Indeed, the
presence of the clpX* allele protected ∆lon cells from hypersensitivity to the
proteotoxic amino acid L-canavanine (Figure 3B). We conclude that ClpX* has
an altered substrate preference, that includes DnaA, SciP, and unfolded proteins,
whose degradation are normally governed by the Lon protease.
2.4.4 ClpX*P is deficient in degradation of native ClpXP substrates
Mutations in ClpX that improve recognition of some substrates can have
negative consequences on others (Farrell et al., 2007). GFP-ssrA is a wellcharacterized ClpXP substrate that is directly bound by the pore loops of ClpX
(Fei et al., 2020; Gottesman et al., 1998). We purified GFP fused to the
Caulobacter ssrA tag (Chien, et al. 2007), determined degradation rates by
ClpX*P and ClpXP, and fit these rates to the Michaelis-Menten equation. We
found that ClpX*P degrades GFP-ssrA more poorly than wildtype ClpXP,
principally lowering the turnover rate (Figure 4A, Figure S5A), suggesting that
either ClpX* fails to bind the ssrA tag as readily or is unable to translocate the
reporter protein as well as ClpX. This effect was not due to the GFP as an ssrA-
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tagged unfolded titin domain was also degraded more slowly by ClpX*P (Figure
S5B). Given that the β20-tagged version of this same construct was degraded
more rapidly (Figure S4D), we conclude that the altered specificity of ClpX* must
rely on the recognition tag identity, rather than on changes in substrate
translocation
CtrA is a master regulator in Caulobacter that inhibits replication initiation
and regulates the transcription of many cell-cycle genes (Laub et al., 2002;
Wortinger et al., 2000). In vivo, CtrA is degraded during the G1-S transition by
ClpXP through the use of an adaptor hierarchy (Domian et al., 1999; Jenal and
Fuchs, 1998; Joshi et al., 2015; Quon et al., 1996); however, in vitro CtrA can
also be directly recognized by ClpXP as its C-terminus resembles the ssrA tag
(Chien et al., 2007). Consistent with a reduced ability to recognize ClpXP
substrates, ClpX*P degrades isolated CtrA more poorly than wildtype (Figure 4B)
and also shows reduced degradation of a CtrA-derived GFP reporter (Smith et
al., 2014) in the presence of the full adaptor hierarchy (Figure S5C). We
conclude that ClpX*P overall has a diminished ability to recognize and degrade
native substrates normally degraded by ClpXP.
2.4.5 Deficiencies of ClpX* revealed when Lon is present
The prior in vitro data suggests that rather than just expanding specificity,
this mutation has allowed ClpX*P to degrade Lon-dependent substrates better
but at the cost of degrading ClpXP-dependent ones. If this is true, while clpX* is
beneficial in a Δlon background, we reasoned that it may be detrimental to lon+
cells.
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To test this hypothesis, we generated a strain with clpX* as its sole copy.
We first examined ssrA tag turnover in this strain by using an ssrA derivative that
relies on the SspB adaptor for degradation (eGFP-ssrA(DAS)) (Chowdhury et al.,
2010) so that degradation would be sufficiently slowed to be visualized by
western blotting. Consistent with our in vitro experiments, we observed
stabilization and dramatically higher levels of eGFP-ssrA (DAS) in the clpX*
strain in comparison to wildtype (Figure 4C). We observed reduced CtrA
degradation in the clpX* strain, consistent with our in vitro observations (Figure
4C). Finally, DnaA degradation is accelerated in the clpX* strains compared to
wildtype – consistent with our findings that both Lon and ClpX*P are able to
degrade DnaA (Figures 4C).
To assess the overall impact of ClpX* on wildtype cells, we performed
competition assays as described previously using a wildtype strain constitutively
expressing the Venus fluorescent protein (Persat et al., 2014). We found that
while nonfluorescent wildtype cells could slightly outcompete the constitutive
Venus expressing cells, the clpX* strain showed a substantial competitive
disadvantage (Figure 4D). We also tested for stress tolerances and found that
clpX* strains fail to survive genotoxic stress as robustly as wildtype (Figure 4E).
Our conclusion is that reduced fitness of the wildtype clpX* strain is likely due to
reduced degradation of normal ClpXP substrates (such as CtrA) and prolific
degradation of normal Lon substrates (such as DnaA) that together reduce
overall fitness. Collectively, this supports our understanding that AAA+
proteases have been optimized for specific priorities in a cell – expansion of their
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substrate profile, as seen with clpX*, can compensate for loss of other proteases,
but at the cost of their ability to recognize their normal substrates.
2.4.5 Limiting ATP alters wildtype ClpXP substrate specificity
To understand how this mutation in ClpX leads to enhanced degradation
of certain substrates, we further characterized the ATPase activity of ClpX*.
While ClpX* hydrolyzes ATP three-fold faster than wildtype ClpX at saturating
ATP concentrations (Figure S4A), Michaelis-Menten experiments showed that
the KM increases by 5-6 fold and the catalytic efficiency for ATP hydrolysis
decreases by approximately 2 fold (Figure 5A). While KM does depend on kcat,
the magnitude of KM increase given the change in kcat suggests that there is also
deficiency in nucleotide binding of ClpX*. To test this, we used ATP to compete
off mant-ADP, a fluorescent ADP analog and we observed at least a three-fold
increase in the IC50 for ClpX*, suggesting that it binds ATP worse than wildtype
ClpX (Figure S6A). However, to make sure that the observed difference in the
IC50 between ClpX and ClpX* was due to changes in nucleotide binding and not
because of the hydrolysis of ATP in the assay, we also competed off mant-ADP
using ATPγS and assayed changes using fluorescence polarization. Consistent
with the ATP titration described above, we calculated higher IC50s for ATPγS in
the presence of ClpX* (Figure S6B)
As seen previously, degradation of GFP-ssrA is precipitously lost below a
minimum threshold of ATP (Martin et al., 2008), with the ClpX*P threshold being
higher than that of wildtype, consistent with the higher KM for ATP described
above (Figure S7A). For ClpX*P, casein degradation reduced monotonically as
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ATP concentration was lowered (Figure 5B). In striking contrast, we found that
for wildtype ClpXP, casein degradation was increased at intermediate nucleotide
concentrations compared to saturating ATP (Figure 5B). Kinetic analysis shows
that at these lower ATP concentrations ClpXP degrades casein with a lower K M
and a similar Vmax compared to saturating ATP conditions (Figure 5C). Since KM
= KD + kcat/kon, the lower KM rate suggests that, at a minimum, casein must bind
better to ClpX at these concentrations.
These results suggest that ClpX specificity depends on ATP concentration
in an unexpected fashion, with lower levels of ATP facilitating ClpX recognition of
some substrates. We reasoned that this could explain the altered specificity of
the ClpX* mutant, as its increased KM for ATP may allow ClpX* to resemble a low
ATP state even under saturating ATP conditions (Figure 5A). Remarkably, this
enhanced degradation at low ATP extended to other ClpX* substrates, such as
DnaA and SciP (Figure 5D and S7B). We conclude that ClpX preference
depends on ATP state, with its specificity expanded under limiting ATP
conditions.

This in vitro data suggests that ClpXP may be better at degrading some
substrates such as DnaA in vivo under conditions in which ATP levels are
limiting. To test this, we monitored degradation of DnaA during starvation using a
∆lon ∆clpA strain which should eliminate any non-ClpX dependent degradation
(Liu et al., 2016). Glucose starvation has been shown to accelerate DnaA
degradation (Gorbatyuk and Marczynski, 2005) which we found true for wildtype
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cells as well (Figure 5E). Importantly, starving ∆lon ∆clpA also markedly
increased DnaA degradation (Figure 5E) concurrent with a reduction in bulk ATP
levels (Figure S7C).
We next considered how conformational changes in ClpX might explain
the altered specificity at low ATP. Using limited proteolysis to probe
conformational differences we found that ClpX at low ATP was more protease
accessible than at high ATP (Figure 6A). Consistent with the shared altered
specificity, protease accessibility of ClpX* at high ATP resembled the wildtype
ClpX at low ATP (Figure 6A). This suggests that ClpX* adopts a state resembling
the low ATP condition of ClpX, which we propose is more open of a structure
than that found with ClpX under high ATP conditions. We next used differential
scanning fluorimetry (DSF) to measure changes in stability, reasoning that if
ClpX* was more likely to occupy the open state, as suggested by limited
proteolysis, we would see a shift in thermal stability compared to wildtype ClpX
even with saturating ATP. Consistent with the limited proteolysis, we found that
ClpX* was destabilized in comparison to wildtype ClpX at high ATP (Figure 6B).
As expected, limiting ATP for wildtype ClpX also resulted in less thermal stability
as ATP binding is known to be needed for ClpX oligomerization (Hersch et al.,
2005).

Finally, we performed hydrogen-deuterium exchange coupled with mass
spectrometry (HDX-MS) to determine specific regions of ClpX and ClpX* that
differ in dynamics. As expected with ATP being needed for ClpX oligomerization,
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we observed significantly more deuterium uptake spanning the entire sequence
of ClpX under limiting ATP conditions (Figure S8A). We next compared ClpX and
ClpX* at saturating ATP and found that ClpX* peptides generally showed faster
exchange than the equivalent peptides from wildtype ClpX (Figure 6C; S8B-C).
One of these peptides (residues 186-200) was the most deprotected in ClpX*
compared to ClpX and is buried in the pore of the closed substrate-bound
structure of ClpX (Protein Data Bank ID: 6PO1) (Figure 6C, Figure S8C). We
created an open state model of ClpX by aligning six monomers with the AAA
domains of substrate-free Lon from Yersinia pestis that is in an open state
(Protein Data Bank ID: 6V11; Shin et al., 2020). The peptide corresponding to
residues 186-200 was no longer buried in this modeled structure, consistent with
our model that ClpX* can more readily adopt an open state (Figure S8C). We
propose that in the closed state, the regions responsible for the ATP-dependent
shift in substrate specificity are buried, leading to worse substrate degradation for
substrates like FITC-Casein. Under limiting ATP or in the presence of ClpX*,
these regions are more exposed, leading to enhanced recognition and
degradation of certain substrates. We hypothesize that this low ATP-induced
conformational difference may reflect the observed differences in AAA+
structures depending on substrate loading seen in recent cryo-EM studies and
discuss their ramifications below.
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2.5 Discussion
Because proteolysis is irreversible, degradation of substrates must be
carefully monitored to avoid toxic consequences. In bacteria, different energy
dependent proteases have distinct substrate preferences that allows them to
collectively regulate proteome dynamics. However, how these energy-dependent
proteases choose their target substrates from a pool of cellular proteins remains
poorly understood. Certain determinants that dictate specificity include degrons,
or degradation tags, such as the ssrA tag which marks proteins for degradation
by ClpXP or ClpAP (Keiler, 2015; Keiler et al., 1996). Specificity can be
augmented through adaptor proteins that help deliver substrates to proteases.
For example, degradation of CtrA in Caulobacter is restricted to the ClpXP
protease via a highly regulated series of adaptors (Joshi et al., 2015).
In this work, we identified a mutant allele of clpX (clpX*) that compensates
for the loss of Lon through expanding ClpXP substrate specificity. The variant
ClpX*P protease complements the growth, motility, replication status, and
morphology defects of a ∆lon strain (Figure 1A-1C) by restoring levels and
degradation of the Lon substrates DnaA and SciP (Figure 2), which we confirm
with biochemical experiments (Figure 3). Interestingly, ClpX*P has an improved
ability to degrade unfolded protein substrates, a feature that likely explains the
increased proteotoxic tolerance of ∆lon clpX* strains (Figure 3). Finally, this clpX
variant is deficient in proteolysis of normal ClpXP substrates, such as CtrA and
ssrA-tagged proteins, suggesting a shift in substrate preference rather than just
an expansion (Figure 4). Mechanistic enzymology revealed that ClpX* requires
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~5-fold more ATP for saturation (Figure 5A), leading us to explore the role of ATP
levels in controlling specificity. Surprisingly, our in vitro studies found that
wildtype ClpXP is better at degrading unfolded proteins, DnaA, and SciP in ATP
limiting conditions, but worse at degrading ssrA-tagged proteins, similar to that
seen with ClpX*P in saturating ATP (Figure 5B, 5D, S7B). We recapitulate this
effect in vivo, showing that in starvation conditions that deplete ATP, DnaA
degradation by wildtype ClpXP is accelerated (Figure 5E). Our interpretation is
that the ClpX oligomer adopts distinct conformations in the ATP-saturated and
ATP-limited conditions, as suggested by limited proteolysis as well as DSF and
HDX-MS experiments (Figure 6, S8A-S8C).
How does altered ATP loading alter substrate recognition? Our working
model is that ClpX normally samples an 'open' state and a 'closed' state to
capture substrates, and the closed state can engage ClpP to form a processive
protease that uses cycles of ATP hydrolysis to power unfolding and degradation
(Figure 6D). Substrates can be captured during the open-closed transition (as we
propose for casein) or directly by the closed state (as proposed for the ssrA tag
and ClpXP (Hersch et al., 2005; Fei et al., 2020). Recent cryo-EM structures
reveal shared features of substrate-bound AAA+ complexes, namely a shallow
right-handed ring with pore loops gripping the substrate and at least 4 ATPbound protomers (Fei et al., 2020; Gates et al., 2017; Lopez et al., 2020; Ripstein
et al., 2020; Shin et al., 2020), while substrate-free forms of these machines
show more open, often left-handed, spiral structures (Shin et al., 2020; Yokom et
al., 2016). Interestingly, the original crystals of ClpX shows a left-handed open
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spiral packing (Kim and Kim, 2003), similar to substrate-free cryo-EM structures
described for other AAA+ machines.
We propose that limiting ATP or mutations can shift the open/closed
balance toward the open state, which allows ClpX to better capture certain
substrates, such as unfolded proteins, which may not have as strict sequence
requirements for recognition (Figure 6). However, degrons such as the ssrA tag
which bind selectively to the closed conformation (Hersch et al., 2005) would be
poorly recognized in these conditions. Interestingly, it was previously shown that
mutation in the RKH loop of ClpX decreases degradation of ssrA tagged proteins
but increases degradation of other substrates (Farrell et al., 2007). These
mutants were also reported to have a 2-fold increase in the maximum ATP
hydrolysis rate compared to wildtype, similar to the ClpX* variant characterized
here; however, the KM was not reported in that earlier work. Together with our
current findings, it seems that specificity for ClpX is surprisingly plastic and
dependent on features that alter ATP hydrolysis rates.
Prior work has shown that limiting nucleotide leads to loss of substrate
degradation by ClpXP (Martin et al., 2008), as would make sense for an ATPfueled unfoldase. We note that these studies exclusively used ssrA-tagged
substrates, which requires an ATP-bound (and presumably closed) form of ClpX
for recognition. Thus, the equivalent effects we are seeing here for casein, DnaA,
and SciP would not have been previously observed. This dichotomy also
highlights the importance of using a range of substrates in understanding activity.
The open-capture / closed-processive model described here also has
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precedence in the conformational states and activity of Hsp104 (Gates et al.,
2017; Ye et al., 2020; Yokom et al., 2016), where doping in nonhydrolyzable ATP
analogs results in enhanced unfolding activity (Doyle et al., 2007). In our current
work, we suggest that different states of ClpX, favored by either limiting ATP or
mutation, can result in meaningful biological consequences. Intriguingly, similar
conclusions were drawn for the chaperonin GroEL, where mutants with a shifted
specificity that improves folding of one class of clients at the expense of others
also resulted in an altered ATPase cycle attributed to changes in conformational
lifetimes (Wang et al., 2002). Overall, it seems that exclusive substrate profiles
for AAA+ systems are not hard-wired but can be altered not only by mutations
but also through modulation of ATP hydrolysis, demonstrating a plasticity in
these machines that yield flexibility in maintaining cellular proteostasis.
2.6 Limitations of the study
While our final model that ATP affects the dynamics of open/closed
oligomerization of ClpX satisfies our biochemical and cellular results, we
recognize there are limitations in the experimental support of our model. Because
ClpX* has a higher KM for ATP and has properties similar to that of wildtype ClpX
under limiting ATP conditions, the most parsimonious interpretation is that ClpX*
at saturating ATP mimics ClpX under limiting ATP in terms of mechanisms
changing substrate specificity. However, it is possible that ClpX* has shifted
substrate preference for a reason completely different than why wildtype ClpX
under limiting ATP conditions has a shifted specificity. Because we have not
directly measured ATP loading, we cannot say whether ClpX or ClpX* differs in
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nucleotide occupancy at saturating ATP concentrations. A final concern is that
although open apo-state spirals and closed substrate-bound rings have been
found for several AAA+ family members (as described above), these have yet to
be seen for ClpX. The most concrete evidence for ATP-driven changes in
open/closed ClpX states would be structural snapshots with different levels of
ATP and with the ClpX* mutant that would demonstrate how these states were
populated. This is beyond the scope of this current work; however, we are
engaged in pursuing these studies.
2.7 Materials and Methods
Bacterial strains and growth conditions
Bacterial strains and plasmids used in this study are listed in
supplementary file 2. Caulobacter crescentus strains were grown in PYE medium
(2g/L peptone, 1g/L yeast extract, 1 mM MgSO4, and 0.5 mM CaCl2) at 30°C. To
generate strains, antibiotics were added to plates at the following concentrations:
kanamycin (25 μg/ml), spectinomycin (100 μg/ml), and oxytetracycline (2 μg/ml).
After initial selection steps for strain construction (excluding plasmids), antibiotics
were excluded for all assays. For C. crescentus motility assays, PYE with 0.3%
agar was used and a single colony was stabbed into the agar using a sterile tip
and left to incubate at 30°C for 2 to 3 days.
Escherichia coli strains were grown in LB (10g/L NaCl, 10g/L tryptone,
5g/L yeast extract) and supplemented with antibiotics at the following
concentrations: ampicillin (100 ug/ml), oxytetracycline (15 μg/ml), spectinomycin
(50 μg/ml), kanamycin (50 μg/ml), gentamycin (20 μg/ml). For solid medium,
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1.5% agar was used regardless of bacterial species. For all strains, optical
density was measured at 600 nm.
For induction purposes, the 477 plasmids were induced with xylose (0.2%)
and repressed with glucose (0.2%). For protein expression, 0.4 M IPTG was
used for induction.
Cloning and strain constructions
All Caulobacter strains were derived from CPC176, an isolate of NA1000.
To generate the Δlon clpX* strain, a two-step recombination protocol with a
sucrose counter selection was utilized (Skerker et al., 2005). The vector
pNPTS138 was digested with HindIII and EcoRI. A PCR product of the clpX*
sequence was amplified from the original motility suppressor and Gibson
assembly was then used to generate pNPTS138_clpX*. Following transformation
with pNPTS138_clpX* into NA1000 or Δlon, primary selection was on PYE
supplemented with kanamycin. Primary colonies were grown overnight without
selection and overnight cultures were played on PYE agar supplemented with
3% w/v sucrose. To validate allelic swap, strains were tested for sensitivity to
kanamycin. Δlon clpX* was also screened by motility and sequencing of the clpX
locus validated candidate clones.
ClpX or clpX* merodiploid strains were generated by Gibson assembly of
PCR product and double digested plasmids of pMCS-2. The plasmids were then
electroporated into Δlon and selected onto kanamycin plates. Strains were
validated by anti-ClpX westerns.
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eGFP-ssrA(DAS) induction strains were generated by electroporating
eGFP-ssrA(DAS) 477 plasmid into wildtype and wildtype clpX* and selecting on
spectinomycin. Strains were validated by anti-M2 westerns.

Motility Suppressor screen
Transposon libraries were generated for Δlon. Two-liter PYE cultures were grown
to mid exponential phase, pelleted, and washed with 10% glycerol. Competent
cells were electroporated with Ez-Tn5 <Kan-2> transposome (Lucigen, Madison,
WI). Cells recovered for 90 minutes at 30 °C and then played on PYE plates
supplemented with kanamycin. Libraries were grown for 7 days. Colonies were
then scraped from the surface, combined, and resuspended to form a
homogenous solution of PYE + 20% glycerol.

The Tn library was thawed out and diluted into a flask containing two-liter 0.3%
agar. The cell agar mixture was plated and grown at 30 °C for 3 to 5 days.
Candidates that appeared motile were validated by innoculating single colonies
into motility agar on the same plate as NA1000 as a positive control and Δlon as
a negative control and incubating plates for 2-3 days at 30 °C.
Whole genome sequencing
Genomic DNA was extracted using the MasterPure Complete DNA and
RNA purification kit (Epicenter Biotechnologies, Madison, WI). A Qubit
Fluorometer (ThermoFisher Scientific, Waltham, MA) was utilized to assess DNA
concentration. Illumina libraries were generated from the extracted genomic DNA
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using the NexteraXT (Illumina, San Diego, CA) protocol. Libraries were
multiplexed and sequenced at the University of Massachusetts Amherst
Genomics Core Facility on the NextSeq 500 (Illumina). Single nucleotide
polymorphisms (SNPs) were detected using breseq (Deatherage and Barrick,
2014).
RNA sequencing
RNA was extracted from stationary phase cells. Libraries were generated from
the extracted RNA using the NEB Next RNA Library Prep kits (NEB, Ipswich,
MA). Libraries were sequenced at the University of Massachusetts Genomics
Core Facility on the NextSeq 500 with single end 75 base reads. Reads were
mapped to the Caulobacter genome using BWA (Li and Durbin, 2009) and sorted
with Samtools (Li et al., 2009).To obtain the number of reads per gene, bedtools
map (Quinlan and Hall, 2010) was used. Rstudio and EdgeR was used to identify
differentially expressed genes (R Core Team, 2019; Robinson et al., 2009).
Raw counts were normalized using the counts-per-million (CPM) method,
and the edgeR package in R was used to perform differential gene expression
analysis, KEGG pathway analysis, and FRY (Wu et al., 2010) gene set analysis.
We filtered out any gene that had less than 30 normalized counts across 3 or
more samples. To test for gene expression differences and identify differentially
expressed genes across experimental groups, we used the quasi-likelihood Ftest. The over-representation analysis for KEGG pathways done using the kegga
function. FRY gene set analysis done using the fry function. The CcrM, DnaA,
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and SciP regulons were obtained from (Gonzalez et al., 2014; Hottes et al., 2005;
Tan et al., 2010).
Plating viability and drug sensitivity
All Caulobacter strains were grown overnight in liquid PYE media. After overnight
growth, cells were back diluted to OD600 0.1 and outgrown to mid-exponential
phase before being normalized to OD600 0.1 and 10-fold serially diluted on to
media. For experiments using mitomycin C (Sigma, St. Louis, MO) and Lcanavanine (Sigma), drugs were prepared at a stock concentration of 0.4 μg/ml
mitomycin C, and 100 mg/ml L-canavanine and filter sterilized. PYE agar was
cooled before the drugs were added and plates were left to air dry prior to serial
dilution plating. All plates were incubated at 30 ̊C for 2-3 days and imaged with a
gel doc.
In vivo assays
The stability of proteins in vivo was determined by inhibiting protein synthesis
upon addition of 30 μg/ml chloramphenicol to cells in exponential phase. At each
time point, 1ml of culture was removed and centrifuged at 15,000 rpm for 2
minutes. The supernatant was removed and pellets were flash frozen in liquid
nitrogen. Pellets were thawed, resuspended in 2x SDS dye, and normalized to
the OD600 of the lowest sample. Samples were boiled for 10 minutes and
centrifuged for 10 minutes at 15,000 rpm. Extracts were run on 10% Bis-Tris gels
for 1 hour at room temperature at 150 V. Gels were then transferred to
nitrocellulose membranes for 1 hour at room temperature at 20V. Membranes
were blocked with 3% milk in Tris-based saline with 0.05% Tween-20 (TBST) for
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1 hour. Membranes were probed with primary antibody in 3% milk in TBST at
4°C overnight with following dilution factors: 1:5000 dilution of DnaA, 1:5000
SciP, 1:5000 CcrM, 1:5000 ClpP, 1:2500 Lon, and 1:2000 M2. Membranes were
washed with 1x TBST for 5 minutes three times and then probed with Licor
secondary antibody with 1:10,000 dilution in 1x TBST at room temperature for 1
hour. The protein was visualized using Licor Odyssey CLx. Bands were
quantified using imageJ and degradation rates were plotted using Prism.
To synchronize Caulobacter strains, cells were grown to an OD600 of 0.30.5 in PYE and swarmer cells were isolated using Percoll density centrifugation.
Cells were released into PYE.
Flow cytometry was used to measure DNA content in rifampicin-treated
cells as previously described (Chen et al., 2009). Cells were rifampicin treated for
three hours prior to fixing in 70% ethanol.
Carbon Starvation
Cells were grown in M2G media (6.1 mM Na2HPO4, 3.9 mM KH2PO4, 9.3 mM
NH4Cl, 0.5 mM MgSO4, 0.5 mM CaCl2, 10 µM FeSO4 (EDTA chelate),
0.2% glucose). Cells were then washed twice in cold M2G media (+glucose
samples) or in M2 media (-glucose samples) and resuspended in pre-warmed
M2G or M2 media.
For bulk measurements of intracellular ATP, the Bactiter-Glo microbial cell
viability assay kit (Promega) was used. Cells were mixed with an equal volume of
BacTiter-Glo reagent in 384-well microtiter plates and incubated for five minutes
before luminescence was measured.
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Growth competition assay
Overnight cultures of CPC798 were mixed with either NA1000 or clpX* at a 1:1
ratio. For competition assays with Δlon strains, overnight cultures of CPC807
were mixed with either Δlon or Δlon clpX* at a 1:1 ratio. Mixed strains were
diluted into fresh PYE and allowed to outgrow for 12 doublings overnight. The
initial populations were verified by phase contrast and fluorescent microscopy.
Final ratios were normalized to their starting ratios. Data was plotted using
GraphPad Prism.

Microscopy
Phase contrast images of logarithmically growing cells were taken by Zeiss AXIO
Scope A1. Cells were mounted on 1% PYE agar pads and imaged using a 100X
objective. MicrobeJ (Ducret et al., 2016) for ImageJ (Schneider et al., 2012) was
utilized to quantify cell lengths. Stalk lengths were quantified using ImageJ. Prism
was utilized for representations of cell and stalk length measurements.
Representative images of the same scale were cropped to display morphological
defects.
Protein Purification and Modification
Untagged Lon, untagged ClpX and ClpX*, and his-tagged ClpP were purified as
previously described (Chien et al., 2007b; Goldberg et al., 1994; Gur and Sauer,
2008b; Levchenko et al., 2000). Titin-I27-β20 and Titin-I27-ssrA were purified as
previously described (Gur and Sauer, 2008b; Kenniston et al., 2003) and labeled
with Fluorescein-5-maleimide (Thermo ScientificTM) under guanidine
hydrochloride denaturation. The modified protein was buffer exchanged into H-
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buffer (20 mM Hepes pH 7.5, 100 mM KCl, 10 mM MgCl2, 10% glycerol) and
stored at 4°C. The concentration of fluorescein-modified Titin-I27-β20 and TitinI27-ssrA were determined using the Bradford assay (Thermo ScientificTM). FITCCasein (Type III, Sigma) was prepared in water and stored at -20°C. His6SciP
and his6CtrA were purified as described in (Gora et al., 2013b). DnaA and CcrM
were purified as his6SUMO tagged proteins, followed by tag cleavage as
described (Jonas et al., 2013; Liu et al., 2016; Wang et al., 2007). GFP-ssrA was
purified as previously described (Yakhnin et al., 1998). CtrA-RD+15 was purified
as described (Smith et al., 2014b). Detailed purification protocols are available
upon request.

In vitro reconstitution assays
Degradation assays were performed at 30°C and monitored using SDS-PAGE
gels as described previously (Bhat et al., 2013). The final concentrations used
can be found in the figure legends. Densitometry was performed with ImageJ and
degradation rates were plotted using Prism.
Degradation of FITC-Casein, FT-Titin-B20, and FT-Titin-ssrA was
monitored as an increase in fluorescence over time. GFP-CtrARD+15
degradation was observed as a loss of fluorescence over time as described
previously (Smith et al., 2014b).
ATP hydrolysis for ClpXP and ClpX*P was measured using a coupled
kinase assay as previously described (Burton et al., 2003)
Limited Proteolysis
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To perform limited chymotrypsin digestion, 0.004 mg/mL chymotyrpsin was
added to 0.01 mg/mL ClpX or ClpX* in the presence of ClpP and ATP
regeneration system and incubated at 25°C in Hepes buffer (20 mM Hepes pH
7.5, 100 mM KCl, 10 mM MgCl2, 10% glycerol) for indicated time points. To
quench the reactions, 5X SDS dye supplemented with 5 mM Protease inhibitor
phenylmethylsulfonyl fluoride (PMSF) was added. The samples were run on a
10% Bis-Tris gel and transferred to nitrocellulose as described above.
Membranes were probed with primary antibody in 3% milk in TBST at 4°C
overnight with following dilution factors: 1:5000 dilution of ClpX. Membranes were
washed with 1x TBST for 5 minutes three times and then probed with Licor
secondary antibody with 1:10,000 dilution in 1x TBST at room temperature for 1
hour. The protein was visualized using Licor Odyssey CLx.

Binding of ADP to ClpX
625 nM mant-ADP was pre-incubated with 300 nM ClpX6/ClpX6* for 10 minutes.
Subsequently, ATPγS was added to compete off the mant-ADP at various
concentrations. Polarization measurements were read from 20 uL of these
mixtures after an additional 15 minute incubation using opaque black 384-well
plates and a SpectraMax M5 plate reader (Molecular Devices), with excitation
and emission wavelengths set at 357 and 445 nm, respectively. IC50s were
calculated by fitting the polarization data using GraphPad Prism to an inhibitor
versus response – variable slope (four paramaters) function in GraphPad Prism:
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Y=Bottom + (Top-Bottom)/(1+(IC50/X)^HillSlope) where IC50 is the ATPγS
concentration halfway between bottom and top.
Differential Scanning Fluorimetry
Differential scanning fluorimetry was carried out in a Biorad realtime PCR
thermocycler. 6 μM monomer of ClpX or ClpX* in the presence of 4 mM ATP or
12 μM ATP was mixed in a 1∶1 ratio with 4X Sypro Orange in Hepes Buffer (20
mM Hepes pH 7.5, 100 mM KCl, 10 mM MgCl2). The resulting mixtures were
incubated at room temperature for 30 mins to allow the Sypro Orange to coat the
proteins before subjecting triplicate samples to thermal unfolding from 25 °C to
95 °C. Melting temperatures were calculated by fitting of a 5-parameter sigmoid
curve using the JTSA software (P. Bond, https://paulsbond.co.uk/jtsa).
Hydrogen-deuterium exchange mass spectrometry (HDX-MS)
Hydrogen-deuterium exchange experiments were carried out on a Synapt G2Si
high-definition mass spectrometer (Waters) using an automated HDX robotics
platform (Waters). Samples of 5.4 μM ClpX or ClpX* monomer were diluted 1:16
in D2O buffer containing 20 mM Hepes, 10 mM MgCl2, 100 mM KCl, and 5%
glycerol. D2O and H2O buffers were supplemented with 4 mM ATP plus
regeneration system (30 mM creatine kinase and 0.5 mg/mL creatine phosphate)
for the high ATP condition and 12 μM ATP for the low ATP condition. Deuterium
exchange was allowed to take place for 0, 10 seconds, 1 min, 10 minutes, and
60 min at 25 °C. The samples were subsequently quenched by addition of cold
quench buffer (233 mM Sodium Phosphate pH 2.5) and run over an immobilized
Waters ENZYMATE immobilized pepsin column (inner diameter: 2.1 × 30 mm) at
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a flow rate of 0.15 mL/min at high pressure (∼11,000 psi) for peptide digestion.
Blank runs were run in between each analysis to avoid peptide carry over.
Continuous lock-mass correction was performed using leu-enkephalin
compound. Peptides were ionized and separated by electrospray ionization for
analysis at a mass resolution of 50 to 2,000 m/z range. Peptides were identified
with triplicate undeuterated samples from each condition. Identification of
peptides and analysis of the uptake plots and charge states for each peptide
were completed in Protein Lynx Global Server and DynamX (v. 3.0, Waters). The
following processing paramaters were utilized: minimum peptide intensity of
1000, minimum peptide length of 5, maximum peptide length of 30, minimum
MS/MS products of 2, minimum products per amino acid of 0.25, minimum score
of 5, and maximum MH+ error threshold of 15 p.p.m. Woods plots were
generated by Deuteros (Lau et al., 2021) using the peptide significance test (pvalue <0.01). HDX data summary for each condition was exported from Deuteros
and can be found in Supplementary File 3. No correction was made for backexchange. Specific peptide regions were mapped onto the corresponding
residues in the E. coli cryo-EM structure (PDB ID: 6PO1) using PYMOL (Version
2.5.0, Schrödinger). A model of ClpX in the potential open state was created by
aligning each ClpX monomer to each ATPase monomer of the Y. pestis
substrate-free cryo-EM structure (PDB ID: 6V11) by using the align function in
PYMOL.
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Figure 2.1 Graphical Abstract
AAA+ proteases, such as Lon and ClpXP, collectively regulate protein
homeostasis by degrading distinct substrate. We identify a mutant allele of ClpX,
ClpX*, that has altered substrate specificity, which allows cells to compensate for
the loss of the Lon protease. We find that wildtype ClpX under limiting ATP
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conditions undergoes a similar switch in substrate specificity. We propose that
these changes in substrate preferences are due to alterations in ATP-dependent
conformational dynamics.

Figure 2.2 : clpX* mutant suppresses lon phenotypes

89

A. Growth curves of wild type (wt), lon, and lon clpX* cells grown in PYE.
Biological triplicate experiments are shown. Error bars represent 95% confidence
interval. Inset shows motility assays as measured by growth in 0.3% PYE agar.
B. Representative phase-contrast microscopy images of wt, lon, and lon clpX*
cells grown in PYE during exponential phase. Quantification of cell length and
stalk length for three biological replicates of n=100 cells.
C. Serial dilution assays comparing colony formation of strains in PYE and PYE
supplemented with mitomycin C. Spots are plated 10-fold dilutions of
exponentially growing cells from left to right.
D. Flow cytometry profiles showing chromosome content of indicated strains after
three-hour treatment with rifampicin. Cells were stained with SYTOX Green to
measure DNA content. The fluorescent intensities corresponding to one
chromosome (1) and two chromosomes (2) are indicated. Experiment was
performed two times. Representative data from one of the biological replicates is
shown here.
E. Venn diagram summarizing the number of differentially expressed genes with
an FDR cutoff < 0.01 from RNA seq performed with stationary phase cells. Venn
diagram created by BioVenn (Hulsen, de Vlieg and Alkema, 2008).
See also Figure S1.
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Figure 2.3: clpX* mutant restores levels of Lon substrates through
degradation
A. Lon degrades DnaA, SciP, and CcrM in C. crescentus (Wright et al., 1996;
Gora et al., 2013; Jonas et al., 2013).
B. Western blot showing DnaA and CcrM levels in wt, lon, and lon clpX* cells.
Lysates from an equal number of exponential phase cells were probed with antiDnaA or anti-CcrM antibody. ClpP was used as a loading control. A
representative image and quantifications of triplicate experiments are shown.
C. Antibiotic shutoff assays to monitor DnaA and CcrM stabilities in wt, lon, and

lon clpX* cells. Chloramphenicol was added to stop synthesis and lysates from
samples at the indicated time points were used for western blot analysis.
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Quantifications of triplicate experiments with substrate shown relative to ClpP
control levels are shown to the right. Error bars represent SD.
D. Western blot showing SciP levels in synchronized populations of wt, lon, and

lon clpX* cells. Swarmer cells were isolated using a density gradient and an
equal number of cells were released into fresh PYE medium. Samples were
withdrawn at the indicated time points and probed with anti-SciP.
E. DnaA stability is measured in ∆lon strains expressing an extra copy of wildtype
clpX or clpX*. Experiment was performed four times. Representative data from
one of the biological replicates is shown here. Quantifications of experiments
shown to the right. Error bars represent SD.
See also Figure S2 and S3.

Figure 2.4: ClpX*P degrades some Lon substrates faster than ClpXP in
vitro.
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A. In vitro degradation of DnaA, SciP, or CcrM. Assays were performed with 0.1
µM ClpX6 or ClpX6*, and 0.2 µM ClpP14. Substrate concentrations were 1 µM
DnaA, 5 µM SciP, 0.5 µM CcrM. Quantification of triplicate experiments shown.
Error bars represent SD.
B. In vitro fluorescence degradation assay of FITC-casein in the presence of
ClpXP or ClpX*P or Lon. Degradation assays were performed with 10g/mL
FITC-Casein, 0.1 µM ClpX6 or ClpX6* and 0.2 µM ClpP14 or 0.1 µM Lon6. Serial
dilution assays comparing colony formation of strains in PYE and PYE
supplemented with L-canavanine. Spots are plated 10-fold dilutions of
exponentially growing cells from left to right.
See also Figure S4.
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Figure 2.5: ClpX* mutant is deficient in degradation of native ClpXP
substrates
A. Michaelis-Menten plot showing the rate of degradation as a function of GFPssrA concentration by ClpXP and ClpX*P. Inset displays kinetic parameters.
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Assays were performed with 0.1 µM ClpX6 or ClpX*6, 0.2 µM ClpP14, ATP
regeneration system, and the indicated concentrations of GFP-ssrA. Data was
fitted to Michaelis-Menten equation. Triplicate experiments are shown.
B. In vitro degradation assay of His-CtrA in the presence of ClpXP or ClpX*P.
Degradation assays were performed with 3 µM His-CtrA, 0.1 µM ClpX6 or ClpX*6,
0.2 µM ClpP14, and ATP regeneration system. Quantification of duplicate
experiments is shown below. Error bars represent SD.
C. In vivo degradation assay showing eGFP-ssrA (DAS), DnaA, and CtrA stability
in wt and clpX* cells. The plasmid encoded M2FLAG-eGFP-ssrA (DAS) construct
was induced with the addition of 0.2% xylose. Chloramphenicol was used to
inhibit protein synthesis. Samples were withdrawn at the indicated time points
and quenched in SDS lysis buffer. Lysate from an equal number of cells was
used for western blot analysis and probed with anti-M2, or anti-CtrA, and antiDnaA antibody. Quantification of triplicate experiments is shown below. Error
bars represent SD.
D. Competition assay with wildtype cells harboring xylX::Plac-venus (constitutive
venus expression) and nonfluorescent wt or clpX* strains. exponential phase
cells were mixed 1:1, diluted, and allowed to outgrow for 12 doublings. .
Quantification of triplicate experiments is shown below. Error bars represent SD.
E. Serial dilution assays comparing colony formation of wt and clpX* cells in PYE
and PYE supplemented with MMC. Spots are plated 10-fold dilutions of
exponentially growing cells from left to right.
See also Figure S5.
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Figure 2.6: Limiting ATP alters wildtype ClpXP substrate specificity
A. Michaelis-Menten plot showing the rate of ClpX/ClpX* catalyzed ATP
hydrolysis as a function of ATP concentration. Inset displays kinetic parameters.
Assays were performed with 0.1 µM ClpX6 or ClpX*6, in the presence and
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absence of 0.2 µM ClpP14. Data was fitted to Michaelis-Menten equation.
Triplicate experiments are shown.
B. FITC-Casein degradation by ClpXP or ClpX*P as a function of ATP
concentration. Assays were performed with 0.1 µM ClpX6 or ClpX*6, 0.2 µM
ClpP14, ATP regeneration system, and 50 µg/mL FITC-Casein. Rates were
normalized to highest concentration of ATP. Non-normalized rates shown in the
inset.
C. Michaelis-Menten plot showing the rate of degradation as a function of FITCCasein concentration by ClpXP under low and saturating ATP conditions. Inset
displays kinetic parameters. Assays were performed with 0.1 µM ClpX6, 0.2 µM
ClpP14, and ATP regeneration system. Data was fitted to Michaelis-Menten
equation. Triplicate experiments are shown.
D. In vitro degradation of DnaA by ClpXP under low and saturating ATP
conditions. Assays were performed with 0.1 µM ClpX6, and 0.2 µM ClpP14 and
0.5 µM DnaA. Quantification of triplicate experiments.
E. Antibiotic shutoff assays to monitor DnaA under ATP limiting conditions in wt
and lon clpA strains. Chloramphenicol was added to stop synthesis and
lysates from samples at the indicated time points were used for western blot
analysis. Quantifications of triplicate experiments shown to the right. Error bars
represent SD.
See also Figure S6 and S7.
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Figure 2.7: ClpX adopts distinct ATP-dependent conformational states
A. Limited proteolysis assay to probe conformational states. ClpX was incubated
with Chymotrypsin with either 12 µM ATP or 4 mM ATP in the presence of ClpP
and ATP regeneration system at 25 °C for the indicated time points. ClpX* was
incubated with Chymotrypsin at 4 mM ATP in the presence of ClpP and ATP
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regeneration system at 25 °C for the indicated time points. ClpX was detected
using anti-ClpX antibodies.
B. Stability of ClpX* with 4 mM ATP, ClpX with 4 mM ATP, and ClpX with 12 µM
ATP as measured by Differential scanning fluorimetry. Triplicate experiments
shown.
C. Woods plot comparing deuterium uptake for wildtype ClpX vs ClpX* at 4 mM
ATP after 60 minutes. Each bar on Woods plot represents a single peptide with
peptide length corresponding to the bar length. Red bars indicate a deprotected
(more deuterium uptake) region, blue represents a protected region, and gray
bars are not significantly different. Woods plots were created with Deuteros (Lau
et al. 2021) using the peptide significance test (p-value <0.01). Residues 186-200
are highlighted in red for the equivalent residues in the substrate-bound E. coli
ClpX structure (Protein Data Bank ID: 6PO1) using PYMOL (Schrodinger).
D. In a wildtype cell, AAA+ proteases Lon and ClpXP promote normal growth by
degrading distinct substrates. ClpX*P can compensate for the absence of the
Lon protease by tuning ClpX substrate specificity to better degrade Lon-restricted
substrates (such as DnaA, SciP, and misfolded proteins) but this comes at the
cost of native ClpXP substrates (such as ssrA-tagged proteins and CtrA). We
propose that ClpX exists in an equilibrium between a closed and open
conformation and promoting one state over the other leads to alterations in
substrate specificity. In the presence of ClpX* or in ATP-limited conditions, ClpX
adopts a more open conformation, allowing capture and recognition of substrates
such as casein. The balance shifts to the closed state under high ATP conditions,
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allowing degradation of substrates such as GFP-ssrA, which preferentially bind
the closed state.
See also Figure S8

Figure 2.8: Validation of motility screen suppressor
(A-B) Motility assay on 0.3% PYE agar of indicated strains.
C. Sequence alignment of ClpX homologs. Conserved glycine residue and
walker B motif are marked.
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D. Quantification of the percent of cells with DNA content of 1N, 2N, and >2N in
wt, Δlon, and Δlon clpX* strains.
E. Competition assay with Δlon cells harboring xylX::Plac-venus (constitutive
venus expression) and nonfluorescent Δlon or Δlon clpX* strains. Exponential
phase cells were mixed 1:1, diluted, and allowed to outgrow for 12 doublings.
Quantification of triplicate experiments is shown below. Error bars represent SD.
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Figure 2.9: RNA-seq gene set analysis
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(A-B) Volcano plot showing the transcriptional differences of Δlon compared to wt
(left) and Δlon clpX* compared to wt (right), as measured by RNA-seq. The
negative log10 of the p value is plotted against log2 of the fold change mRNA
counts. Genes that are marked in red have an FDR <0.05. Transcripts that are
associated with either the SciP regulon (Tan et al., 2010) or cell cycle (KEGG
pathways) are highlighted in blue.
C. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment
analysis and FRY gene set analysis. FRY gene set analysis performed using fry
function from edgeR package in R (Robinson, McCarthy and Smyth, 2009; Wu et
al., 2010). The CcrM, DnaA, and SciP regulons were assigned according to
(Hottes, Shapiro and McAdams, 2005; Tan et al., 2010; Gonzalez et al., 2014).
Over-represented pathways in KEGG pathway database identified using the
kegga function from edgeR package in R.
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Figure 2.10: clpX* mutant is dominant
A. Western blot showing CcrM levels in synchronized populations of wt, lon,
and lon clpX* cells. Swarmer cells were isolated using a density gradient and an
equal number of cells were released into fresh PYE medium. Samples were
withdrawn at the indicated time points and probed with anti-CcrM.
B. Growth curves of wild type (wt), lon, and lon merodiploid with second copy
of clpX* at native locus. Cells grown in PYE.
C. Spot assays comparing colony formation of strains in PYE and PYE
supplemented with mitomycin C.
D. Motility assay on 0.3% PYE agar of indicated strains.
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Figure 2.11: In vitro characterization of ClpX*
A. ATPase activity of 0.1 µM ClpX6/ClpX*6 plus 0.2 µM ClpP14 is displayed.
Triplicate experiments are shown.
B. In vitro degradation of CcrM by 0.2 µM Lon6 is shown as a control. The bottom
gel shows CcrM degradation assay in the presence of ATP, with no regeneration
mix.
C. FITC-Casein titration in the presence of either ClpXP or ClpX*P. Data was fit
to the Michaelis-Menten equation. ClpX*P degrades FITC-Casein 2-3 fold better
than ClpXP.
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F. Fluorescin-Titin-I27-β20 titration in the presence of either ClpXP or ClpX*P.
Data was fit to the Michaelis-Menten equation. Vmax/KM was 30% higher for
ClpX*P in comparison to ClpXP. Inset shows residual plot for Michaelis-Menten
fit.

Figure 2.12: ClpX*P is deficient in native substrate degradation
A. In vitro degradation of GFP-ssrA.
B. Fluorescein-Titin-I27-ssrA titration in the presence of either ClpXP or ClpX*P.
Data was fit to the Michaelis-Menten equation. Vmax/KM was 30% lower for
ClpX*P in comparison to ClpXP. Inset shows residual plot for Michaelis-Menten
fit.
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C. In vitro fluorescence degradation assay of eGFP-CtrA-RD+15 in the presence
of adaptors. Degradation assays were performed with 1 M eGFP-CtrA-RD+15,
0.1 µM ClpX6 or ClpX*6, 0.2 µM ClpP14, 2 M CpdR, 1 M RcdA, 1 M PopA, and
20 M cyclic di-GMP, and ATP regeneration system.

Figure 2.13: ClpX* is deficient in nucleotide binding
A. Titration of ATP against constant mant-ADP (1 µM) in the presence of either
300 nM ClpX6 or ClpX*6 assayed by changes in fluorescence. Data was fit to an
inhibitor versus response – variable slope (four paramaters) function in Graphad
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Prism: Y=Bottom + (Top-Bottom)/(1+(IC50/X)^HillSlope) where IC50 is the ATP
concentration halfway between bottom and top. Two independent replicates
shown.
B. ATPγS competition assay in the presence of either 300 nM ClpX6 or ClpX*6.
Fluorescence polarization of 625 nM mant-ADP was measured as described in
methods. Data was fit as described in A. Two independent replicates shown.

Figure 2.14: Modulating ATP changes substrate preferences
A. GFP-ssrA degradation by ClpXP or ClpX*P as a function of ATP
concentration. Assays were performed with 0.1 µM ClpX6 or ClpX*6, 0.2 µM
ClpP14, ATP regeneration system, and 10 µM GFP-ssrA.
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B. In vitro degradation of SciP by ClpXP under low and saturating ATP
conditions. Assays were performed with 0.1 µM ClpX6, and 0.2 µM ClpP14 and 5
µM SciP. Quantification of triplicate experiments shown.
C. Relative intracellular ATP concentrations measured using a luciferase-based
assay during the course of antibiotic shutoff assay.

Figure 2.15: ClpX* mutation and limiting ATP lead to increased dynamics of
ClpX
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A. Woods plot comparing deuterium uptake for wildtype ClpX at 4 mM ATP vs 12
µM ATP at 60 mins. Each bar on Woods plot represents a single peptide with
peptide length corresponding to the bar length. Red bars indicate a deprotected
(more deuterium uptake) region, blue represents a protected region, and gray
bars are not significantly different. Woods plots were created with Deuteros using
the peptide significance test (p-value <0.01).
B. Woods plot comparing deuterium uptake for wildtype ClpX vs ClpX* at 4 mM
ATP at 0.17, 1, and 10 minutes. Each bar on Woods plot represents a single
peptide with peptide length corresponding to the bar length. Red bars indicate a
deprotected (more deuterium uptake) region, blue represents a protected region,
and gray bars are not significantly different. Woods plots were created with
Deuteros (Lau et al. 2021) using the peptide significance test (p-value <0.01).
C. Comparison of deuterium uptake plots of selected peptides for wildtype ClpX
vs ClpX*.
D. Each ClpX monomer (Protein Data Bank ID: 6PO1) was mapped onto the
substrate-free Lon ATPase domain (Protein Data Bank: 6V11) using PYMOL.
Residues 186-200 highlighted in red.

Supplemental File 2.1- Log file
State A: ClpX_CAUVN (clpx sat atp)
HDX time course (min): 0, 0.17, 1, 10, 60
HDX control samples: None
Back-exchange (mean / IQR): N/A
# of Peptides: 129
Sequence coverage: 93.10%
Average peptide length / redundancy: 13.07 / 4.31
Replicates (technical): 3
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Repeatability: 0.1915 (average SD)
State B: CLPX_CAUVN (clpxg178a sat atp)
HDX time course (min): 0, 0.17, 1, 10, 60
HDX control samples: None
Back-exchange (mean / IQR): N/A
# of Peptides: 125
Sequence coverage: 92.62%
Average peptide length / redundancy: 13.35 / 4.29
Replicates (technical): 3
Repeatability: 0.2475 (average SD)
State B: CLPX_CAUVN (clpx 12um atp)
HDX time course (min): 0, 0.17, 1, 10, 60
HDX control samples: None
Back-exchange (mean / IQR): N/A
# of Peptides: 127
Sequence coverage: 93.10%
Average peptide length / redundancy: 13.23 / 4.30
Replicates (technical): 3
Repeatability: 0.3069 (average SD)

Table 2.1 Strain List
Organism

Name

C.crescentus CPC176

E. coli

Description
Isolate of CB15N/NA1000

CPC456

Δlon (SpecR)

CPC667
CPC753
CPC798
CPC891
CPC963
CPC964
CPC1006
CPC1007
CPC413
CPC807
TOP10

Δlon
Δlon (SpecR) clpXG178A
xylX::PlacZVenus
clpXG178A
wt eGFP-ssrA(DAS)
clpXG178A eGFP-ssrA(DAS)
Δlon PClpX-ClpX
Δlon PClpX-ClpXG178A
ΔClpA Δlon
Δlon xylX::PlacZVenus
Cloning strain
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Source
(Evinger and
Agabian, 1977)
LS2382 (Wright et
al 1996)
This study
This study
This study
This study
This study
This study
This study
This study
Invitrogen

BL21(DE3)
pLysS
EPC100
EPC112
EPC162
BPC238
EPC196
EPC407
EPC 446

recombinant protein
expression
dh5alpha pQE70-his-ClpP
BL21DE3 pLysS pET23
Ulp1his protease
BL21DE3 375 eGFP-His6CtrARD+15
BL21DE3 plysS pET23 ClpX
BL21DE3 plysS pET23b
His6Sumo-CpdR
Top10 pBXMCS-2
BL21DE3 plysS pET23b
His6SUMO CcrM

Invitrogen
(Chien et al., 2007)

(Smith et al., 2014)
(Chien et al., 2007)
(Lau et al., 2015)

(
EPC677

BL21DE3 plysS 375 His6TacA
Joshi et al., 2015)

EPC970
EPC1000
EPC1037
EPC1508

EPC1562

BL21DE3 plysS pET23b
His6Sumo-RcdA
TOP10 pET23b His6SumoRcdA
BL21DE3 plysS pET23b
His6Sumo-PopA
Delta ClpX W3110 pBAD
GFPS65T ccssrA
BL21DE3 plysS pBAD33
His6Sumo DnaA
BL21DE3 plysS pET23
ClpXG178A
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(Joshi et al., 2015)
(Joshi et al., 2015)
(Joshi et al., 2015)

This study

Figure 2.16 Uncropped western blot for Figure 2.2B

Figure 2.17 Uncropped western blot for Figure 2.2C
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Figure 2.18 Uncropped western blot for Figure 2.2D

Figure 2.19 Uncropped western blot for Figure 2.2E
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Figure 2.20 Uncropped gels for Figure 2.3A
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Figure 2.21 Uncropped western blot for Figure 2.4C

Figure 2.22 Uncropped gel for Figure 2.5D
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Figure 2.23 Uncropped western blot for Figure 2.5E
2.11 Additional data not included in manuscript

Figure 2.24 dsDNA modulates the degradation of DnaA by the Lon and
ClpXP proteases
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The addition of dsDNA stimulates Lon to degrade DnaA. However, addition of
dsDNA to ClpX*P as well as ClpXP slows down DnaA degradation. Our working
model for this is that Lon sluggishly degrades DnaA on its own. However, in the
presence of this dsDNA, Lon can also bind it and cause faster degradation of
DnaA. This contrasts with ClpXP and ClpX*P which cannot bind DNA so DnaA
degradation is slowed down.

Figure 2.25 DnaAR357A is degraded robustly by ClpX*P and ClpXP.
Previous work has shown that Lon and ClpAP both can degrade DnaA although
it was hypothesized that they might recognize different nucleotide bound versions
of DnaA (Liu et. al 2016). DnaAR357A is a constitutively ATP-bound DnaA
mutant that has been shown to be degraded poorly by Lon and degraded with a
similar half-life to wildtype DnaA by ClpAP. We observed that the R mutant was
degraded robustly by ClpX*P and by ClpXP although the rate of DnaA
degradation by ClpX*P was still faster than ClpXP, similar to what we observed
for wildtype DnaA.
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Figure 2.26 DnaA and SciP degradation by ClpXP is dependent on the Nterminal domain.
A-B. N ClpXP fails to degrade DnaA (0.5 uM). GFP-ssrA degradation is shown
as a control for N ClpXP activity. Quantification shown below.
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C. N ClpXP fails to degrade SciP (5 uM). GFP-ssrA degradation is shown as a
control for N ClpXP activity. Quantification shown below.
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Figure 2.27 Substrate addition alters the ATPase rate of ClpX and ClpX*
Previous studies have shown that the ATPase rate of wildtype ClpX is decreased
in the presence of ClpP and increased in the presence of GFP-ssrA (Kim et al.
2001, Burton et al. 2003). Given that we observed faster DnaA degradation and
slower GFP-ssrA degradation by ClpX*P, we wondered if we would see similar
effects on the ATPase rate of ClpX* in the presence of GFP-ssrA, DnaA, and
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ClpP. Unlike the slight depression in ATPase rate observed for wildtype ClpX in
the presence of ClpP, the addition of ClpP to ClpX* led to a stimulation of ATP
hydrolysis. We also observed a drop in the ATPase rate of ClpX* in the presence
of both DnaA and GFP-ssrA, suggesting that the effects on proteolysis were not
mirrored by the ATPase rates. This data also suggests that wildtype ClpX and
ClpX* recognize substrates differently since GFP-ssrA increases the ATPase
rate of ClpX but decreases the ATPase rate of ClpX*.
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Figure 2.28 Titration of ClpX/ClpX*. Here we titrated ClpX and ClpX* and
monitored ATPase rates. We found that more ClpX* was needed to start
hydrolyzing ATP (Khalf 54 nM vs 19 nM) than wildtype ClpX, suggesting that
ClpX* requires ~ 3 fold more enzyme to assemble fully. This data seems to fit
well with the data in our manuscript showing that ClpX* is more open (as
demonstrated by HDX-MS) and less stable (as demonstrated by DSF).

2.12 ClpX* Purification
This protocol is modified from the Chien lab native CCX purification protocol with
some adjustments
Buffers:
Lysis buffer/ Phenyl Sepharose buffer B/ Q-Sepharose buffer A
50 mM Tris, pH 8
100 mM KCl
5 mM MgCl2
10% glycerol
5mM DTT
Phenyl Sepharose buffer A
Same as PS-B, but with 0.5M AmSO4
Q-Sepharose buffer B
1X Lysis buffer
1M KCl
5mM DTT
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1. Start an overnight from EPC1562 AMP plate
2. The next morning, back dilute the overnight culture 1:1000 (6L is sufficient
as a grow-up)
3. Grow cells to a high density at 37C (I normally induce at >0.8)
4. Shift cells to 30C and induce with 0.4 mM IPTG and grow for another 4
hours at 30C
5. Take gel sample and ensure ClpX* was induced.
6. After induction, spin cells at 7K rpm for 8 mins
7. Resuspend cells in lysis buffer and store at -80C.
8. Thaw cells on ice when ready to begin purification
9. Add 1 mM final amount of PMSF ( I make 100 mM stock in isopropyl
alcohol fresh day of purification)
10. Disrupt cells at 18K psi, pass through microfluidizer 3 times
11. Take sample of lysate for gel
12. Spin lysate at 15K g for 30 mins
13. Transfer supernatant into graduated cylinder to find final volume of
supernatant
14. Using the Encorbio AmS04 calclate, find the amount of AmSO4 needed to
create a 50% sat’d solution starting from a 0% initial saturation
https://www.encorbio.com/protocols/AM-SO4.htm
15. Take sample of supernatant for gel
AmSO4 cut
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1. In the cold room, use the magnetic stir plate and gently agitate the
supernatant in a beaker.
2. Over the course of an hour, add small amounts of the total AmSO4
calculated above
3. After the last bit is added, let the solution stir at 4C for at least 1hr
4. Take sample for gel
5. Centrifuge the Supernatant /AmSO4 mix in the fixed angle rotor at 5K g for
30 mins
6. Carefully pour off supernatant and save
7. Take sample of AmSO4 supernatant for Gel
8. Gently resuspend pellet in minimal amount of Lysis buffer that has no
PMSF (about the same volume as was when spun down) (This is where
ClpX is supposed to be)
9. After allowing as much of the precipitate as possible to resolubilize, respin
the resuspended pellet for 15mins at 5K g and take supernatant into new
container.
10. Run a 10% TG gel of uninduced, induced, Lysate, 1 st Sup, Pellet, AmSO4
sat’d, AmSO4 spun sup, and resuspended (clarified) AmSO4 pellet
11. If the gel shows that the protein is in the resuspended pellet, then you
need to test the salinity of the resuspended solution and match it to the
salinity of PS-A
Matching ClpX* conductivity to that of PS-A
1. Make a sat’d AMSO4 solution of Lysis buffer (10mls, 6.97g AmSO4)
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2. Dilute PS-A (20 uL in 20 mL of water).
3. Measure the salinity of PS-A diluted with the Orion 013005MD conductivity
probe
4. Measure the salinity of diluted resuspended pellet
5. Titrate in the sat’d AmSO4 Lysis buffer into resuspended pellet until the
salinity matches that (can be a smidgeon higher that) of PS-A
Phenyl Sepharose column
1. Equilibrate PS-A column
2. Load the resuspended pellet into the superloop
3. Inject superloop onto the PS column at 5ml/min, make sure to add
manufacturer recommended pressure alarms
4. Switch to load once all the sample is injected
5. Wash column until the A280 reaches that of the pre-equilibrated state
6. Wash with 50%B and do so until the A280 reaches baseline as before
7. Start elution, setting gradient to 100% in 60 mins with a flow rate of 2 mL
per min. Collect 2 mL fractions.
8. Run gel to choose which fractions to pool. I don’t normally run an activity
assay at this point.
Matching ClpX* conductivity to that of PS-A
1. Check salinity of pooled fractions against QS-A, it should be LOWER than
QS-A, if not, dilute in 50 mM Tris pH 8, 10% glycerol buffer (lysis buffer
with no salts)
QFF column
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1. Equilibrate QFF column
2. Load the pooled fractions into the superloop
3. Inject superloop onto the column at 5ml/min, make sure to add
manufacturer recommended pressure alarms
4. Switch to load once all the sample is injected
5. Wash column with 100% A until the salinity reaches that of the preequilibrated state
6. Start gradient from 0%B to 100%B in 75 min
7. Run 10% TG gel of the fractions and run GFP-ssrA activity assay (This is
critical because I have observed some ClpX* fractions that seem to have a
lot of protein but have no activity)
MonoQ column
1. Equilibrate monoQ column
2. Load the pooled fractions into the superloop
3. Inject superloop onto the column at 1ml/min, make sure to add
manufacturer recommended pressure alarms
4. Switch to load once all the sample is injected
5. Wash column with 100% A until the salinity reaches that of the preequilibrated state
6. Start gradient from 0%B to 40%B in 30 min
7. Run 10% TG gel of the fractions and run GFP-ssrA activity assay
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Figure 2.29 Yield and purity of ClpX*
While I have been able to achieve high purity for ClpX*, the yield (200, 10 ul
aliquots at 0.5-0.75 uM hexamer) is often much lower than what we get for
wildtype ClpX (200, 10 ul aliquots at more than 2 uM hexamer).
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Chapter Three

Quantitative Proteomics Screen Uncovers Novel Phenotypes

Contributions: I performed all the sample preparation for the proteomics
experiments described in this chapter. I also did all the analysis described here to
identify potential Lon substrates and the follow-up experiments showing
polymyxin B sensitivity in a lon strain and suppression in a lon clpX* strain.
Caiqin Wang, a rotation student in our lab, did the transposon suppressor screen
identifying suppressors of lon’s polymyxin B sensitivity which mapped back to
CcbF. Berent Aldikacti added the proteomics data to the Chienlab browser with
the hopes of having this tool publicly available to anyone interested in looking at
our proteomics data. Patrick Cann helped with the first phase of the TMT
analysis, specifically comparing our dataset to the one published by Kristina
Jonas’ lab.
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3.1 Abstract
Energy-dependent proteases maintain protein quality control by recognizing and
degrading protein substrates that perform various cellular tasks. The biological
significance of removing these cellular targets in a timely manner is highlighted
by the defects in growth and stress responses that arise in the absence of one or
more AAA+ proteases. However, to date, the degradome, consisting of the full
repertoire of substrates for each protease, is not fully elucidated. Here, we
present a quantitative proteomics approach which is amenable to multiple strains
and various conditions. We utilize translational shutoffs to compare protein
abundance and degradation rates in a wildtype, lon, and a strain
overexpressing the Lon protease to identify putative Lon substrates. We
performed similar experiments with a previously identified suppressor, lon clpX*
and identified preferential degradation of CcbF by ClpX*. We uncover that lon,
cells are sensitive to polymyxin B, a novel phenotype, and screen for
suppressors, which mapped back to CcbF, highlighting the utility of this approach
in uncovering new phenotypes and related pathways.

3.2 Introduction
Maintenance of protein homeostasis is essential for survival. Bacteria utilize
energy-dependent AAA+ proteases to degrade misfolded and regulatory
proteins. There are several energy-dependent proteases that exist in bacteria,
including Lon, ClpXP, ClpAP, HslUV, and FtsH (Mahmoud and Chien, 2018).
These proteases are comprised of an AAA+ unfoldase and a compartmentalized
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peptidase. The ATPase assembles into a hexameric ring with a central pore
which undergoes ATP-dependent conformational changes that drive unfolding
and translocation of protein substrates into the peptidase chamber, where
irreversible destruction takes place (Sauer and Baker, 2011).
First discovered in Escherichia coli, Lon is a highly conserved member of
the AAA+ family and is found in all domains of life (Gottesman, Halpern and
Trisler, 1981). Posttranslational regulation by the Lon protease plays an
important role in a range of cellular processes, including motility and
pathogenesis (Breidenstein et al., 2012; Rogers et al., 2016). While Lon is
principally known as a quality control protease, responsible for the degradation of
approximately 50% of misfolded proteins in E. coli, Lon has also been shown to
mediate the destruction of regulatory proteins (Chung and Goldberg, 1981).
However, since its discovery, only a handful of Lon substrates have been
identified. In E. coli, these substrates include the cell-division inhibitor, SulA, and
the positive regulator of capsule synthesis, RcsA (Gottesman, Halpern and
Trisler, 1981; Torres-Cabassa and Gottesman, 1987), and DNA-binding protein
HUβ (Liao et al., 2010).
In the dimorphic alpha-proteobacterium Caulobacter crescentus, the
number of validated Lon substrates remains small. Lon degrades the replication
initiator DnaA, the methyltransferase CcrM, and the transcriptional repressor
SciP (Wright et al., 1996; Gora et al., 2013; Jonas et al., 2013). Recently, more
Lon substrates have been uncovered in Caulobacter, including FixT and the
HipB2 antitoxin (Stein, Fiebig and Crosson, 2020; Zhou, Eckart and Shapiro,
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2021). The developmental regulator StaR and the flagellar regulator FliK were
also recently validated as Lon substrates. StaR and FliK were shown to
contribute to the defects in stalk biogenesis and motility observed in cells lacking
Lon (Omnus et al., 2021).
However, the presently identified substrates likely do not represent the full
repertoire of proteins regulated by the Lon protease. Identifying and validating
more Lon substrates is critical to uncovering novel Lon-related pathways. Here,
we use a quantitative proteomics approach to elucidate the Lon-specific
degradome in Caulobacter. We identify a list of putative Lon substrates by
comparing protein abundance and degradation rates in a wildtype, lon, and Lon
overexpression strain. We used the same proteomics workflow to profile the
degradome of previously reported suppressor, lon clpX* (Mahmoud, Aldikacti
and Chien, 2021). We discovered that CcbF, an enzyme that catalyzes the first
step in ceramide biosynthesis, is preferentially degraded in a lon clpX* strain,
leading to increased resistance to polymyxin B in a lon clpX* in comparison to a

lon strain (Stankeviciute et al., 2019). We then used a lon transposon library to
identify suppressors of polymyxin B sensitivity and found multiple hits in the CcbF
operon, suggesting that lon cells are sensitive to polymyxin B due to
misregulation of CcbF. Together, our work reveals that quantitative proteomics
approaches can provide valuable insight on unexplored pathways and their link
to novel phenotypes.
3.3 Results
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Previous studies have identified the replication initiator, DnaA as a substrate of
the Lon protease in Caulobacter crescentus (Jonas et al., 2013). In wildtype
cells, upon chloramphenicol addition to inhibit protein synthesis, DnaA is robustly
degraded (Figure S1A). In the absence of the Lon protease, DnaA is stabilized,
and steady state levels are increased in comparison to wildtype cells (Figure
S1A). A strain with a C-terminal M2 tag, which protects the Lon protease from
degradation (Barros et al., 2020), and effectively functions as an overexpression
strain, shows decreased DnaA levels upon Lon induction (Figure S1A).We
reasoned that using these strains to perform a quantitative proteomics survey
would allow us to identify new Lon substrates and uncover novel phenotypes.
Triplicate cells were treated with chloramphenicol and samples were
withdrawn at 0, 30 minutes, and 90 minutes post antibiotic addition (Figure 3.1A).
For Lon overexpression, triplicate samples were taken before xylose addition as
well as 2 and 5 hours post addition. Samples were labeled with isobaric tags
using the TMT10plex kit and pooled into three separate TMT experiments for
each strain. The pooled samples were then fractionated using a high pH
reversed-phase peptide fractionation kit (Pierce) into 8 fractions which were then
pooled into 4 fractions and subject to downstream mass spectrometry (Figure
3.1A). To allow comparison between wildtype and lon, we reserved the last
TMT label to serve as a normalization channel comprising of a mixture of the t=0
timepoints (Figure 3.1A). We used a synchronous precursor selection (SPS) MS3
method for reporter ion quantitation (Figure 3.1A). As an example, DnaA showed
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robust degradation in wildtype cells with a half-life of 24.6 minutes and
stabilization in lon cells (Figure 3.1B).
In total, we identified 1347 and 1443 total proteins found in every sample
of wildtype and lon datasets respectively, with 1193 proteins shared between
the two strains (Figure 3.2A). We identified 1155 proteins in the Lon
overexpression strain, with 971 proteins shared between the three strains (Figure
S2A). We compared the proteins we identified in our TMT datasets with protein
expression levels determined by RNA sequencing. We found, as expected, that
the proteins identified in the proteomics survey were the most highly expressed
in our RNA seq experiments, with a higher proportion of proteins identified in the
highest quartiles of expression (Figure S2B). We were particularly interested in a
subset of proteins highly expressed in wildtype cells but absent from the wildtype
proteomics dataset and present in the lon dataset (Figure 3.2B). We identified
49 proteins that fit this criterion (Figure 3.2B, Table S1). We reasoned that these
proteins could represent potential Lon substrates that are degraded rapidly in a
wildtype and, therefore, are undetected in the wildtype proteomics dataset.
Next, we compared the t0/t30 and t0/t90 ratios in a wildtype to determine the
distribution of degradation rates (Figure 3.2C). We reasoned that most proteins
would be stable after 30 and 90 minutes. Indeed, we find that the average t0/t30
and t0/t90 ratios in a wildtype were close to 1 (log2=0). We fit the frequency
distribution to a gaussian and observed an asymmetrical distribution with a tail to
the right which was particularly evident in the t0/t90 comparison (Figure 3.2C).
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This suggested to us, that outside of expected noise in the data, there were
proteins being truly degraded in a wildtype.
Next, we set out to identify potential Lon substrates by combining data
from our 3 TMT experiments. We looked for substrates that would be more
abundant in lon cells (comparing lon t=0 and wt t=0) and degraded in a
wildtype (comparing wt t=0 and t=90) but stabilized in a lon (comparing lon t=0
and t=90). Lastly, we looked for proteins that were less abundant upon Lon
overexpression (comparing Lon O/E t=0 and t=5-hour induction).
We detected known Lon substrates, DnaA, CcrM, and SciP in all samples.
However, we were unable to identify recently reported Lon substrates FixT and
HipB2 (Stein, Fiebig and Crosson, 2020; Zhou, Eckart and Shapiro, 2021). DnaA
was two times as abundant in lon as wildtype and three times more stable (90minute vs 0-minute) (Figure 3.2C). In addition, we found that DnaA levels were
three times lower upon Lon overexpression (5-hour vs uninduced) (Figure S2C).
CcrM was approximately four times more abundant but only 10% more stable in

lon in comparison to wildtype (Figure 3.2C). SciP was approximately 20% more
abundant and more than two times more stable in lon in comparison to wildtype
(Figure 3.2C). CcrM and SciP were both approximately 40% less abundant upon
Lon overexpression (5-hour vs uninduced) (Figure S2C).
We compared the proteome of lon t=0 and wildtype t=0. We set a 25%
false discovery rate (FDR) cutoff, identifying 335 proteins that pass the cutoff
(Figure 3.3A). We then calculated the average lon t0/ wt t0 ratio and determined
the proteins that were found 1, 2, and 3 standard deviations away from the mean.
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We reasoned proteins found 3 standard deviations away from the mean would
likely represent authentic Lon substrates and we find CcrM in this group (Figure
3.3A, Supplementary File 1). DnaA was found in the group of proteins 2 standard
deviations from the mean. We identified 4 proteins in sigma 3, 27 proteins in
sigma 2, and 95 proteins in sigma 1 (Figure 3.3A , Supplementary File 1).
Next, we compared the proteome of wt t=0 and wt t=90 to identify proteins
degraded in a wildtype (Figure 3.3B). We used a 25% FDR cutoff and identified
proteins found 1, 2, and 3 standard deviations from the mean as described
previously (Figure 3.3B). We identified 13 proteins in sigma 3, including DnaA
and Scip, 28 proteins in sigma 2, and 112 proteins in sigma 1 (Supplementary
File 1). To identify which of these proteins are potential Lon substrates, we
compared the proteome of lon t=0 and lon t=90 and then determined which
proteins were degraded in a wildtype but stabilized in a lon, identifying 96 total
proteins fulfilling this criterion (Figure 3.3C). We identified 5 proteins in sigma 3,
14 proteins in sigma 2, and 77 proteins in sigma 3 (Supplementary File 1). As an
example, we identify CtrA, a known ClpXP substrate (Joshi et al., 2015) as being
degraded in both a wildtype and lon but DnaA was only degraded in a wildtype
(Figure 3.3C).
Lastly, we compared the proteome of the uninduced Lon overexpression
strain and t=5-hour induction. We used a 25% FDR cutoff and identified proteins
found 1, 2, and 3 standard deviations from the mean as described previously
(Figure 3.3D). We identified 140 proteins that passed the 25% FDR cutoff. We
then identified 7 proteins in sigma 3, including DnaA, 7 proteins in sigma 2, and
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31 proteins in sigma 1 (Supplementary File 1). We also compared the proteome
of wt t=0 and wt t=30 as well as the proteome of the uninduced Lon
overexpression strain and after 2 hours of induction (Figure S3A-B). Using the 0,
30-minute, and 90-minute datapoints for a wildtype, we calculated half-lives for
219 proteins (Figure S3C, Supplementary File 1).
After we identified which proteins fulfilled each of our criteria separately,
we gave each protein a score. Proteins found 3-SD away from the mean were
given a score of 3, those found 2-SD away were given a score of 2, those found
1-SD away were given a score of 1. The scores were then added up for each
criterion (Supplementary File 1). For example, DnaA tops the list with the highest
score of 8, being more abundant in a lon at t=0 (score of 2), stabilized in a lon
(score of 3), and less abundant upon Lon overexpression (score of 3)
(Supplementary File 1). Overall, we identified 64 putative Lon substrates with a
score of at least two (Supplementary File 1).
A recent proteomics screen identified two new Lon substrates StaR and
FliK (Omnus et al., 2021) using a similar approach to what we describe here.
However, while we did not detect StaR and FliK in our dataset, out of the 64
proteins that we identified as potential Lon substrates, 14 were identified in the
Omnus et al. study as fulfilling either 3 or 4 out of the study’s 4 criteria,
suggesting there is some overlap between the two studies and giving us more
confidence in our dataset (Supplementary File 1).
Next, we performed an additional TMT experiment following translational
inhibition with previously identified suppressor, lon clpX* (Mahmoud, Aldikacti

136

and Chien, 2021). We utilized the normalization channel described above
(mixture of t=0 time points for wildtype, lon, and lon clpX*) to allow
comparisons between the strains. Consistent with our previous work on lon
clpX*, we observed faster degradation of SciP and DnaA in the lon clpX* TMT
dataset in comparison to the lon dataset (Figure 3.4A, 3.4B). Next, we
compared degradation rates in wildtype and lon cells with rates in a lon clpX*
background. We observed that CCNA_01220, recently named CcbF, was
degraded faster in lon clpX* in comparison to both wildtype and lon,
suggesting that ClpX* degrades CcbF faster than wildtype ClpX (Figure 3.4C,
3.4D). Recent work has implicated CcbF in ceramide synthesis in Caulobacter
and deletion of CcbF was shown to increase resistance to polymyxin B, a
lipopolysaccharide interacting antibiotic (Stankeviciute et al., 2019). We reasoned
that if CcbF were a substrate of ClpX*, then lon clpX* should be more resistant
to polymyxin B than lon alone. Indeed, we found that lon cells were highly
sensitive to polymyxin B and this sensitivity was suppressed in the lon clpX*
background, suggesting that CcbF is being turned over by ClpX*, therefore
decreasing its abundance in a lon clpX* background (Figure 3.4E).
We were intrigued that we uncovered a novel phenotype for lon cells and
decided to further explore the relationship between lon cells and polymyxin B.
We used a transposon library generated in a lon background to find
suppressors that increase resistance to polymyxin B. We identified 14
suppressors and used arbitrary PCR to identify the location of the transposon
insertion. We found that 7/14 of the suppressors mapped to the same operon as
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ccbF, suggesting that disrupting this operon is beneficial to restoring polymyxin B
resistance to lon cells.
3.4 Discussion
Bacterial AAA+ proteases, such as Lon and ClpXP, regulate protein homeostasis
by balancing the degradation of misfolded proteins and regulatory proteins. To
fully appreciate the scope of energy-dependent proteolysis inside the cell, it is
imperative to expand our understanding of the specific substrates degraded by
each protease. Here, we present a quantitative proteomics approach to identify
potential Lon substrates (Supplementary File 1). We compared the proteomes of
wildtype, lon, and a Lon overexpression strain to identify substrates that are
more abundant in the absence of Lon, are stabilized in lon cells, and are less
abundant upon Lon overexpression. We compare our dataset to a recently
published quantitative proteomics dataset in Caulobacter (Omnus et al., 2021)
and found some overlap in putative Lon substrates (Supplementary File 1). We
then compared the degradome of lon clpX* to the proteomes of wildtype and

lon. We found that CcbF, a protein responsible for the first step in ceramide
biosynthesis (Stankeviciute et al., 2019), was degraded faster in a lon clpX*
background in comparison to a either a wildtype or lon background (Figure
3.4C, Figure 3.4D). Previous work has shown that deletion of CcbF leads to
increased resistance to polymyxin B. Consistent with faster degradation of CcbF
by ClpX*, we observed increased resistance to the antibiotic polymyxin B in a

lon clpX* compared to a lon, suggesting that CcbF levels are decreased in a
lon clpX* (Figure 3.4E).
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While lon cells have been documented to be sensitive to various
stressors, including agents that cause genotoxic and proteotoxic stress (Zeinert
et al., 2018), we found that lon cells were highly sensitive to polymyxin B in
comparison to wildtype cells. In exploring this novel phenotype further, we
performed a transposon-based suppressor screen to identify suppressors that
restore polymyxin B sensitivity to a lon. We found that half of the transposons
mapped to the CcbF operon, highlighting a link between CcbF misregulation in a

lon and sensitivity to polymyxin B.
Our work highlights the power of using a quantitative proteomics approach
to uncover novel protease-related pathways and to shed light on unexplored
phenotypes. Similar approaches have been taken in mammalian cells where
recent work combined a cycloheximide chase assay with a quantitative
proteomics approach to identify short-lived proteins in human cell lines (Li et al.,
2021). We can envision using a similar approach to map the degradome under
various stress conditions. Similarly, we can extend this approach to identify
substrates degraded by other proteases, such as ClpAP, which only has a few
identified substrates in the literature (Williams et al., 2014; Liu et al., 2016).
Lastly, we can harness the power of quantitative proteomics to identify adaptordependent substrates by comparing the proteomes of wildtype cells and the
proteome of various adaptor deletions, such as CpdR, RcdA, and popA (Joshi et
al., 2015).
3.5 Methods
Bacterial strains and growth conditions
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Caulobacter crescentus strains were grown in PYE medium (2g/L peptone, 1g/L
yeast extract, 1 mM MgSO4, and 0.5 mM CaCl2) at 30°C.
Western blots
The stability of proteins in vivo was determined by inhibiting protein synthesis
with the addition of 30 μg/ml chloramphenicol to cells in exponential phase. At
each time point, 1ml of culture was removed and centrifuged at 15,000 rpm for 2
minutes. The supernatant was removed, and pellets were flash frozen in liquid
nitrogen. Pellets were thawed, resuspended in 2x SDS dye, and normalize.
Samples were boiled for 10 minutes and centrifuged for 10 minutes at 15,000
rpm. Extracts were run on 10% Bis-Tris gels for 1 hour at room temperature at
150 V. Gels were then transferred to nitrocellulose membranes for 1 hour at
room temperature at 20V. Membranes were blocked with 3% milk in Tris-based
saline with 0.05% Tween-20 (TBST) for 1 hour. Membranes were probed with
primary antibody in 3% milk in TBST at 4°C overnight with a 1:5000 dilution of
DnaA. Membranes were washed with 1x TBST for 5 minutes three times and
then probed with Licor secondary antibody with 1:10,000 dilution in 1x TBST at
room temperature for 1 hour. The protein was visualized using Licor Odyssey
CLx.
TMT proteomics and analysis
Strains were grown to mid exponential phase. A 5 ml sample from each strain
was centrifuged in 15 ml centrifuge tubes at 6000g for 5 minutes. The
supernatant was removed, and the pellet was resuspended in freshly made lysis
buffer (8M urea, 50 mM Hepes pH 7.5). The cells were freeze/thawed 3 times in
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liquid nitrogen to aid in cell lysis. The lysates were centrifuged at 16,000g for 10
minutes at 4°C and the supernatant was transferred to a new tube.
A Bradford measurement at OD595 was taken to normalize protein input to
50 ug of each sample. Each sample was reduced using TCEP for 1 hour at
55 °C. The samples were then alkylated with iodoacetamide for 30 mins in the
dark at room temperature. Next, 6 volumes of prechilled acetone were added to
each sample and samples were left overnight at -20°C.
Samples were spun down at 8000g for 10 mins at 4°C. The acetone was
removed, and the acetone-precipitated pellet was resuspended in 100 ul of 50
mM TEAB. Trypsin (2.5 ug) was added to each peptide sample and allowed to
digest overnight at room temperature.
Tandem mass tag labeling was performed using the TMT 10plex kit from
ThermoFisher. Each sample was labeled with the TMT reagent according to the
manufacturer’s protocol. Each TMT label was resuspended in acetonitrile and
then added to each peptide sample. The labeling reaction was allowed to
proceed for 1 hour at room temperature. The reaction was quenched with 5% w/v
hydroxylamine. We utilized the quantitative colorimetric peptide assay (Pierce) to
ensure samples were combined at a 1:1 ratio. The samples were then dried by
speed-vac and resuspended in freshly diluted 0.1% TFA. We then used the high
pH reversed-phase peptide fractionation kit (Pierce) to fractionate each pooled
sample into 8 fractions. We then combined fractions 1 and 5, 2 and 6, 3 and 7,
and 4 and 8 for mass spectrometry analysis.
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An aliquot of each sample was loaded onto a trap column (Acclaim
PepMap 100 pre-column, 75 μm × 2 cm, C18, 3 μm, 100 Å, Thermo Scientific)
connected to an analytical column (Acclaim PepMap RSLC column C18 2 μm,
100 Å, 50 cm × 75 μm ID, Thermo Scientific) using the autosampler of an Easy
nLC 1000 (Thermo Scientific) with solvent A consisting of in 0.1% formic acid in
water and solvent B consisting of 0.1% formic acid in acetonitrile. The peptide
mixture was gradient eluted into an Orbitrap Fusion mass spectrometer (Thermo
Scientific) using a 180 min gradient from 5%-40%B (A: 0.1% formic acid in water,
B:0.1% formic acid in acetonitrile) followed by a 20 min column wash with 100%
solvent B. The full scan MS was acquired over range 400-1400 m/z with a
resolution of 120,000 (@ m/z 200), AGC target of 5e5 charges and a maximum
ion time of 100 ms and 2 s cycle time. Data dependent MS/MS scans were
acquired in the linear ion trap using CID with a normalized collision energy
35%. For quantitation scans, synchronous precursor selection was used to
select 10 most abundant product ions for subsequent MS 3 using AGC target 5e4
and fragmentation using HCD with NCE 55% and resolution in the Orbitrap
60,000. Dynamic exclusion of each precursor ion for 30s was employed.
Mass spectrometry data was processed using Proteome Discoverer 2.2.
For reporter ion quantification, the following parameters were used: a 1.2Da
tolerance, a co-isolation threshold of 75 for MS3, SPS Mass Matches > 65%.
Proteins were searched against the Caulobacter crescentus database. Analysis
was performed with Microsoft Excel and Prism.
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Figure 3.1 Quantitative proteomics workflow. A. Triplicate wildtype and lon
cells were treated with chloramphenicol and samples were withdrawn at 0, 30
minutes, and 90 minutes post chloramphenicol addition. Samples were digested
and labeled with TMT10plex reagents. Samples for each TMT experiment were
pooled and fractionated and analyzed on an Orbitrap Fusion. The last TMT label
was a mixture of t=0 samples and was reserved as a normalization channel to
allow comparisons between wildtype and lon. B. Protein abundance (not
normalized to control channel) and half-life for DnaA in wildtype (top) and lon
(bottom). Half-life for DnaA was calculated by fitting the data to one-phase decay
equation in Prism.
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Figure 3.2 Overview of identified proteins. A. Venn diagram showing the
overlap between the identified proteins in a wildtype and lon. B. Venn diagram
showing the overlap between highly expressed genes in a wildtype (top 75%
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percentile for expression from RNA seq data) not identified in the wildtype
proteomics dataset and proteins identified in the lon proteomics dataset. C.
Frequency distribution of wildtype degradation rates (t=0/t=30, left) and (t=0/t=90,
right). Data was fit to a gaussian distribution in Prism. D. Plot showing protein
abundance triplicates for t=0, t=30, and t=90 for wildtype and lon for known Lon
substrates, DnaA, CcrM, and SciP. Data was normalized to control channel to
allow comparison between wildtype and lon.
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Figure 3.3 Identifying potential Lon substrates. A. Volcano plot comparing the
proteomes of lon t=0 and wildtype t=0 with an FDR cutoff of 25%. B. Volcano
plot comparing the proteomics of wildtype t=0 and wildtype t=90 with an FDR
cutoff of 25%. C. Venn diagram showing overlap of proteins degraded in a
wildtype and proteins degraded in a lon. CtrA was degraded in both strains
while DnaA was degraded in a wildtype. D. Volcano plot comparing the
proteomes of Lon O/E strain t=0 (uninduced) and t=5 hours post induction with
an FDR cutoff of 25%. For all volcano plots, proteins found 1 standard deviation
from the mean (1 sigma) are shown in purple. Proteins found 2 standard
deviations from the mean (2 sigma) are shown in yellow. Proteins found 3
standard deviations from the mean (3 sigma) are shown in teal.
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Figure 3.4 CcbF is preferentially degraded in lon clpX*. A-B. Plot showing
protein abundance triplicates for t=0, t=30, and t=90 for wildtype, lon, and lon
clpX* for DnaA (left) and SciP (right). Data was normalized to control channel to
allow comparison between wildtype, lon, and lon clpX* and normalized to t=0
timepoint. C. Plot showing Log2 (lon clpX* degradation rate/ lon degradation
rate) on the x-axis and Log2 (lon clpX* degradation rate/ wt degradation rate) on
the y-axis. Degradation rate was defined as t=0/t=90 for each strain. CcbF,
DnaA, and SciP are highlighted in red. D. Plot showing protein abundance
triplicates for t=0, t=30, and t=90 for wildtype, lon, and lon clpX* for CcbF.
Data was normalized to control channel to allow comparison between wildtype,

lon, and lon clpX* and normalized to t=0 timepoint. E. Growth curves in the
presence of polymyxin B for wildtype, lon, and lon clpX*. Each strain was
grown in PYE only as a control.
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Figure 3.5 lon suppressors of polymyxin sensitivity map to CcbF operon.
A. Logarithmically growing wildtype and lon were normalized by OD600 and 10fold serial dilutions were plated on PYE and PYE polymyxin B plates. B. 10-fold
serial dilutions of wildtype, lon, and potential lon suppressors plated on PYE
and PYE polymyxin B plates. C. Location of transposon (Tn) insertions in 7
validated lon polymyxin B suppressors.
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Figure 3.6 (Figure S1) Western blots of strains utilized in TMT experiments.
Representative of triplicates of wildtype, lon, and Lon O/E strains. For wildtype
and lon, samples were withdrawn post chloramphenicol addition at the indicated
time points. For the Lon O/E strain, samples were withdrawn post xylose
addition. Lysates were used for western blot analysis and probed with anti-DnaA.
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Figure 3.7 (Figure S2) Lon O/E TMT
A. Venn diagram showing the overlap between the identified proteins in a
wildtype, lon, and Lon O/E strain. B. C. Plot showing t=0, t=2 hour, and t=5 hour
protein abundances in the Lon O/E dataset for DnaA, CcrM, and SciP. Data was
normalized to t=0 timepoint.
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Figure 3.8 (Figure S3) Half-lives of identified proteins
A. Volcano plot comparing the proteomics of wildtype t=0 and wildtype t=30 with
an FDR cutoff of 25%. B. Volcano plot comparing the proteomes of Lon O/E
strain t=0 (uninduced) and t=2 hours post induction with an FDR cutoff of 25%.
For all volcano plots, proteins found 1 standard deviation from the mean (1
sigma) are shown in purple. Proteins found 2 standard deviations from the mean
(2 sigma) are shown in yellow. Proteins found 3 standard deviations from the
mean (3 sigma) are shown in teal. C. Plot showing normalized protein
abundances at t=0, t=30, and t=90 in a wildtype strain for all proteins where a
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half-life calculation was possible. Half-lives were calculated using the one-phase
decay equation in Prism.

Figure 3.9 CcbF in vitro degradation assay in the presence of 0.1 uM ClpX and
ClpX*. GFP-ssrA degradation assay shown as a positive control to ensure ClpX
is active.
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Chapter 4
Suppression Analysis Reveals Lon-related Pathways
Contributions: I performed the transposon-based and spontaneous suppressor
screens to pull up the hits discussed in this chapter. I detailed our understanding
of suppressor 18 (lon clpX*) in chapter 2 of this thesis. Additional
characterizations beyond this chapter have been completed by Patrick Cann,
especially for suppressor 25. He has also done some wonderful work on using
translational inhibitors to suppress lon defects.

4.1 Abstract
Caulobacter crescentus cells lacking the AAA+ protease Lon are non-motile and
sensitive to various stressors. Here, we screen for lon motility suppressors
using both a transposon-mutagenesis approach and a spontaneous suppressor
approach. We identify motility suppressors that also suppressed other lon
defects including filamentation and response to Mitomycin C. We identified a
spontaneous motility suppressor that has a deletion of the 16s ribosomal RNA,
suggesting a link between Lon and translation. We explore this link further by
showing that decreasing translation through either slowing down growth or low
levels of translational inhibition is beneficial for lon cells. Lastly, we show that
there are other ways to suppress lon defects including deletions of ssrA and
smpB and pyruvate dehydrogenase.
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4.2 Introduction
Energy-dependent proteases are found in all domains of life. They are critical for
driving normal growth and response to stresses (Mahmoud and Chien, 2018).
Lon is a highly conserved member of the AAA+ (ATPases associated with
diverse cellular activities) family and is primarily known for degrading misfolded
proteins (Goff, Casson and Goldberg, 1984). In addition to its role in removing
damaged and unfolded proteins, Lon plays a role in degrading regulatory
proteins as well, including the replication initiator DnaA, the methyltransferase
CcrM, and the transcriptional repressor SciP in Caulobacter crescentus (Wright
et al., 1996; Gora et al., 2013; Jonas et al., 2013).
Although cells lacking Lon are still viable, they exhibit multiple defects,
including filamentation and decreased motility on soft agar (Wright et al., 1996;
Leslie et al., 2015). However, it is not always clear why lon cells exhibit these
defects and if these defects arise from stabilization of certain Lon substrates in
cells lacking Lon. In some cases, there is a direct link between a lon defect and
stabilization of a direct Lon target. For example, recent work has established a
link between elongated stalks in lon cells and stabilization of the developmental
regulator and newly discovered Lon substrate, StaR (Omnus et al., 2021).
However, for some lon phenotypes, the effect is indirect. For example, lon
cells are more resistant to hydroxyurea (HU), a known inhibitor of ribonucleotide
reductase (RNR). Recent work has suggested that stabilization of the Lon
substrate, CcrM, transcriptionally upregulates RNR, explaining why lon cells are
resistant to HU (Zeinert et al., 2020).
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Here, we use a suppressor screen approach to identify suppressors of

lon’s motility defect. We identify motility suppressors that also restore stress
responses to lon cells. We pull up a suppressor with a deletion of the 16s
ribosomal RNA, hinting at a potential link between the Lon protease and
translation. We find that slowing down growth or using low levels of translational
inhibition is beneficial in lon cells. Finally, we uncover other ways to suppress

lon defects.
4.3 Results
Cells lacking the Lon protease are non-motile when grown on soft agar (Figure
4.1A). We generated a transposon-library in a lon background to identify
suppressors that restore motility to lon cells. We inoculated 0.3% PYE agar with
the lon transposon library and looked for colonies that showed enhanced
motility. We then validated these targets and found three suppressors that
increased motility in a lon background (Figure 4.1B). We named these
suppressors #18, #22, and #25 (Figure 4.1B).
We further characterized these three suppressors and found that in
addition to restoring motility to lon cells, these suppressors also suppressed
filamentation (Figure 4.1C) and sensitivity to Mitomycin C (Figure 4.1D).
To identify the site of the transposon insertion in suppressors 18,22, and
25, we performed sequential PCR amplifications using arbitrary primers and a
Tn-5 specific primer. We found that suppressor 18 had a transposon insertion in
CCNA_00264, annotated as a C4-dicarboxylate transport protein. Suppressor 22
had a transposon insertion in phosphate regulon response regulator phoB and
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suppressor 25 had a transposon insertion in CCNA_01509, annotated as 3oxoacyl synthase III.
Next, we asked whether the transposon insertion was responsible for the
phenotypic rescue described above. To answer this, we used a Caulobacterspecific phage, Cr30, to move the transposon and surrounding regions to a new

lon background, which would be free of any background mutations that could
have been present in the original lon strain. We then checked the motility of the
resulting phage transductions. We reasoned that if the transposon insertion was
the reason for the motility rescue, these strains should remain as motile as the
original isolated suppressors. However, we found that for all three suppressors,
moving the transposon insertion into a fresh lon background did not restore
motility to lon cells (Figure 4.2A). This suggested to us that the mutation
responsible for the motility rescue observed in the original suppressors was a
spontaneous mutation. To identify these spontaneous suppressor mutations, we
performed whole genome sequencing on suppressors 18, 22, and 25.
Whole genome sequencing revealed that suppressor 18 had a single point
mutation in the ClpX protease. We have recently explored the mechanism behind
how this clpX point mutant is able to rescue lon defects (Mahmoud, Aldikacti
and Chien, 2021). Suppressor 22 has a frameshift mutation in the developmental
regulator and ClpXP substrate, TacA (Biondi et al., 2006). We next asked if this
mutation led to non-functional TacA protein. Indeed, we performed western blots
on suppressors 18, 22, and 25 in addition to wildtype and tacA as controls and
found that TacA was not expressed in suppressor 22, like a tacA strain (Figure
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4.2B). However, we found that a lon tacA strain was not as motile as the
original 22 suppressor, suggesting that the phenotypic rescue was not due to
deletion of tacA in a lon (Figure 4.2B).
Suppressor 25 had a point mutation upstream of the coding region of the
master regulator and ClpXP substrate, CtrA. This mutation occurs upstream of
the P1 promoter in the GANTC methylation motif for CtrA (Reisenauer, 2002).
Intriguingly, this methylation site is acted on by CcrM, a Lon substrate, where
methylation acts to inhibit CtrA transcription. We reasoned that altering this
methylation site might alter CtrA’s methylation status which would be mis
regulated in the absence of Lon and the resulting buildup of CcrM.
In addition to the CtrA methylation mutation, whole genome sequencing of
suppressor 25 revealed a single point mutation (N87K) in the S1P protein. We
reasoned that since the transposon insertion could not explain the phenotypic
rescue observed with suppressor 25, the rescue could be explained by either the
CtrA methylation mutation or the S1P mutation or a combination of the two
mutations. We created a lon strain with the mutation in the CtrA methylation site
and tested motility. We did not find that this strain was as motile as the original
suppressor 25 and reasoned that mutating the CtrA methylation site on its own is
not sufficient to suppress motility (Figure 4.2C).
Given that our previous suppressor screen using a transposon library did
not lead to any hits due to the transposon insertions, we reasoned that we might
be able to find spontaneous motility suppressors in lon background directly. To
do this, we inoculated lon cells into 0.3% PYE agar and looked for flares,
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indicative of increased motility. We identified three promising suppressors, which
we named 5, 7, and 9 (Figure 4.3A). However, upon validation we observed that
5,7, and 9 only marginally increased motility in lon (Figure 4.3A). Instead, we
found that these strains suppressed Mitomycin C sensitivity, especially
suppressor # 5 which was as resistant to Mitomycin C as wildtype (Figure 4.3B).
In addition, suppressor 5 was less filamentous than lon cells (Figure 4.3C). We
did whole genome sequencing and found that suppressor 5 had a deletion of
CCNA_R0069, which is the 16S ribosomal RNA, and two neighboring genes,
CCNA_02708 and CCNA_02709. This suggested that it was beneficial to delete
16S ribosomal RNA in a lon. We next wondered if this mutation was slowing
down translation and somehow that was beneficial in cells lacking Lon.
Next, we explored other ways to slow down translation and their impact on

lon cells. We grew lon cells and lon clpA cells in PYE, a nutrient-rich media,
and M2G, a defined media which slows down growth rate (Hottes et al., 2004).
We found that in PYE, lon and lon clpA cells were highly filamentous (Figure
4.4A). This filamentation was suppressed in M2 media with 0.2% glucose and in
M2G with 0.04% glucose (Figure 4.4A). Similarly, we monitored growth of
wildtype, lon, and lon clpA cells in PYE, M2 with 0.2% glucose, and M2 with
0.04% glucose. We observed that lon was not able to grow as well as wildtype
cells, exhibiting a lag and growing to a lower stationary phase OD, as previously
reported (Figure 4.4B) (Mahmoud, Aldikacti and Chien, 2021). lon clpA cells
exhibited a much longer lag in comparison to both wildtype and lon, eventually
reaching the same final OD as lon (Figure 4.4B). In M2 with 0.2% glucose, the
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lag for lon clpA was much less pronounced and wildtype and lon grew
similarly (Figure 4.4B). In M2 with 0.04% glucose, the three strains were
comparable in growth, although they only doubled two times before reaching
saturation (Figure 4.4B). We also grew wildtype and lon cells in M5G media and
observed a similar trend in phosphate-replete conditions (Figure 4.4C). This data
suggested to us that slowing down translation by slowing down growth is
beneficial in cells lacking Lon and in those lacking Lon and ClpA.
Next, we tested directly if slowing down translation was beneficial in cells
lacking Lon. We exposed wildtype and lon cells to PYE plates supplemented
with Mitomycin C and to plates supplemented with Mitomycin C and low amounts
of chloramphenicol, a translational inhibitor. We found that lon cells were more
sensitive to Mitomycin C than wildtype cells (Figure 4.5A). However, addition of
chloramphenicol made lon cells more resistant to Mitomycin C, suggesting that
slowing down translation allows lon cells to better respond to DNA damage
(Figure 4.5A).
Next, we explored other ways to suppress lon defects. In bacteria,
proteins whose synthesis has stalled are cleared and marked for degradation in a
process called trans-translation (Karzai, Roche and Sauer, 2000). This system is
mediated by a ribosome-bound ssrA RNA and a protein factor, SmpB. We found
that deleting either ssrA or SmpB restored some DnaA degradation in a lon
strain, where DnaA is stabilized (Figure 4.6A). We explored whether motility was
suppressed in a lon smpB or a lon ssrA strain and did not observe any
increase in motility. We also observed some restoration of DnaA degradation in a
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lon popA strain, which was intriguing because it is another ClpXP substrate
(Joshi et al., 2015), suggesting there an interplay between the two protease
pathways.
Lastly, we found that lon’s filamentation defect was suppressed in a lon
strain with a deletion of pyruvate dehydrogenase (Figure 4.7A). While we saw
that DnaA degradation was somewhat enhanced in a lon pyruvate
dehydrogenase strain, this effect was not consistent. We also did not see any
suppression of Mitomycin C sensitivity or L-canavanine sensitivity in a lon

pyruvate dehydrogenase strain.
4.4 Discussion
The importance of AAA+ proteases is highlighted by the defects in growth and
response to stress that arises in their absence (Breidenstein et al., 2012; Rogers
et al., 2016). In Caulobacter crescentus, cells lacking Lon are non-motile, have
elongated cell and stalk length, and are sensitive to various stressors (Mahmoud,
Aldikacti and Chien, 2021; Omnus et al., 2021). In this study, we sought to
identify novel Lon-related pathways by looking for suppressors of lon’s motility
defect. We pull up three suppressors in the ClpXP pathway, a point mutation in
ClpX, a frameshift mutation in TacA, a ClpXP substrate, and a mutation in the
promoter region of CtrA, another ClpXP substrate (Figure 4.1, 4.2). We also
found that deleting popA, a ClpXP adaptor, in a lon restored some DnaA
degradation (Figure 4.6). These suppressors suggest that the Lon and ClpXP
protease pathways are not independent but that changes that affect one pathway
can be corrected by alterations to the other pathway.
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We also identified a spontaneous motility suppressor, 5, that had a
deletion in the 16S ribosomal RNA (Figure 4.3). This suggests that somehow
slowing down translation in a lon is beneficial. We further explore this link by
finding that other ways that slow down translation, such as growth in minimal
media or the addition of translational inhibitors to lon cells, are beneficial to lon
cells. It is intriguing to think about a connection between the Lon protease and
the process of translation. Afterall, proteases break down proteins into their
component amino acids, which then go on to serve as fuel for making more
proteins. For instance, inhibition of the eukaryotic proteasome is lethal due to the
resulting shortage of amino acid pools (Suraweera et al., 2012). In the absence
of degradation, perhaps there is a shortage of amino acid pools which can be
replenished by slowing down translation. However, working is ongoing to
elucidate the mechanism governing the benefit of translational inhibition in a

lon.
4.5 Methods
Bacterial strains and growth conditions
Strains were grown in PYE medium (2g/L peptone, 1g/L yeast extract, 1 mM
MgSO4, and 0.5 mM CaCl2) or M2G (6.1 mM Na2HPO4, 3.9 mM KH2PO4, 9.3 mM
NH4Cl, 0.5 mM MgSO4, 10 μM FeSO4[EDTA chelate], 0.5 mM CaCl2, and 0.2%
glucose as the sole carbon source) or M5G ( 10 mM PIPES, pH 7, 1 mM NaCl,
1 mM KCl, 0.05% NH4Cl, 0.01 mM Fe/EDTA, 0.2% glucose, 0.5 mM MgSO4,
0.5 mM CaCl2 and 10 mM phosphate) at 30°C.
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For C. crescentus motility assays, PYE with 0.3% agar was used and a
single colony was stabbed into the agar using a sterile tip and left to incubate at
30°C for 2 to 3 days.
For solid medium, 1.5% agar was used. For all strains, optical density was
measured at 600 nm.
Motility Suppressor screen
Transposon libraries were generated for Δlon cells. Two-liter PYE cultures were
grown to mid log phase, pelleted, and washed with 10% glycerol. Competent
cells were electroporated with Ez-Tn5 <Kan-2> transposome (Lucigen, Madison,
WI). Cells recovered for 1.5 hours at 30 °C and then plated on PYE + kanamycin
plates. Libraries were grown for 7 days. Colonies were then scraped from the
surface, combined, and resuspended to form a homogenous solution of PYE +
20% glycerol.
The Tn library was thawed out and diluted into a flask containing two-liter
0.3% agar. The cell agar mixture was plated and grown at 30 °C for 3 to 5 days.
Candidates that appeared motile were validated by innoculating single colonies
into motility agar on the same plate as NA1000 as a positive control and Δlon as
a negative control and incubating plates for 2-3 days at 30 °C.

The motility screen with spontaneous suppressors was performed by inoculating
a 2L flask of 0.3% PYE agar with diluted Δlon cells. The cell agar mixture was
plated and grown at 30 °C for 3 days. Candidates that appeared motile were
validated by innoculating single colonies into motility agar on the same plate as
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NA1000 as a positive control and Δlon as a negative control and incubating
plates for 2-3 days at 30 °C.
Whole genome sequencing
Genomic DNA was extracted using the MasterPure Complete DNA and
RNA purification kit (Epicenter Biotechnologies, Madison, WI). A Qubit
Fluorometer (ThermoFisher Scientific, Waltham, MA) was utilized to assess DNA
concentration. Illumina libraries were generated from the extracted genomic DNA
using the NexteraXT (Illumina, San Diego, CA) protocol. Libraries were
multiplexed and sequenced at the University of Massachusetts Amherst
Genomics Core Facility on the NextSeq 500 (Illumina). Single nucleotide
polymorphisms (SNPs) were detected using breseq (Deatherage and Barrick,
2014).
Plating viability and drug sensitivity
All Caulobacter strains were grown overnight in liquid media. After overnight
growth, cells were back diluted to OD600 0.1 and outgrown to mid-exponential
phase before being normalized to OD600 0.1 and 10-fold serially diluted on to
media. For experiments using mitomycin C (Sigma, St. Louis, MO) and Lcanavanine (Sigma), drugs were prepared at a stock concentration of 0.4 μg/ml
mitomycin C. PYE agar was cooled before the drugs were added and plates
were left to air dry prior to serial dilution plating. All plates were incubated at 30 ̊C
for 2-3 days and imaged with a gel doc.
In vivo assays
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The stability of proteins in vivo was determined by inhibiting protein synthesis
upon addition of 30 μg/ml chloramphenicol to cells in exponential phase. At each
time point, 1ml of culture was removed and centrifuged at 15,000 rpm for 2
minutes. The supernatant was removed and pellets were flash frozen in liquid
nitrogen. Pellets were thawed, resuspended in 2x SDS dye, and normalized to
the OD600 of the lowest sample. Samples were boiled for 10 minutes and
centrifuged for 10 minutes at 15,000 rpm. Extracts were run on 10% Bis-Tris gels
for 1 hour at room temperature at 150 V. Gels were then transferred to
nitrocellulose membranes for 1 hour at room temperature at 20V. Membranes
were blocked with 3% milk in Tris-based saline with 0.05% Tween-20 (TBST) for
1 hour. Membranes were probed with primary antibody in 3% milk in TBST at
4°C overnight with a 1:5000 dilution of DnaA. Membranes were washed with 1x
TBST for 5 minutes three times and then probed with Licor secondary antibody
with 1:10,000 dilution in 1x TBST at room temperature for 1 hour. The protein
was visualized using Licor Odyssey CLx. Bands were quantified using imageJ
and degradation rates were plotted using Prism.
Microscopy
Phase contrast images of logarithmically growing cells were taken by Zeiss AXIO
Scope A1. Cells were mounted on 1% PYE agar pads and imaged using a 100X
objective. MicrobeJ (Ducret et al., 2016) for ImageJ (Schneider et al., 2012) was
utilized to quantify cell lengths. Representative images of the same scale were
cropped to display morphological defects.
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Figure 4.1 Using transposon mutagenesis to screen for motility
suppressors. A. Set-up of motility screen. Wildtype cells are more motile than
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Δlon cells. B. Validation of hits from motility screen compared to wildtype and
Δlon on 0.3% PYE agar and morphology of wildtype, Δlon, Suppressors 18, 22,
and 25. C. MMC spot assays. These are 10-fold serial dilutions of the indicated
strains on PYE and PYE + MMC plates.

Figure 4.2 Validation of motility suppressors. A. Motility assays after phage
transduction was used to move the transposon insertions into fresh Δlon strains.
The resulting strains were no longer motile. B. Western blot showing suppressor
22 is not expressing TacA protein. Controls include ΔtacA and wildtype cells.
Motility on 0.3% PYE agar showing Δlon ΔtacA is non-motile. C. Motility on 0.3%
PYE agar showing Δlon cells with the CtrA promoter mutation are non-motile.
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Figure 4.3 Spontaneous motility suppressors. A. Validation of spontaneous
motility suppressors 5, 7, and 9 on 0.3% PYE agar. B. MMC spot assays of
indicated strains. These are 10-fold serial dilutions of exponentially growing cells
on PYE and PYE supplemented with the indicated concentrations of MMC.
Suppressors 5, 7, and 9 suppress Δlon’s sensitivity to MMC. C. Microscopy of
indicated strains in PYE.
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Figure 4.4 Minimal media suppresses Δlon defects. A. Microscopy of Δlon
and Δlon ΔclpA cells grown in PYE, M2G (0.2% glucose), and M2G (0.04%
glucose). B. Growth curves of wildtype, Δlon and Δlon ΔclpA cells in PYE, M2G
(0.2% glucose), and M2G (0.04% glucose). C. Microscopy of Δlon and wildtype
cells grown in M5G plus 10 mM phosphate and M5G no phosphate.
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Figure 4.5 Spot assays of Δlon and wildtype cells on PYE, PYE + MMC, PYE +
MMC + chloramphenicol.

Figure 4.6 A. Antibiotic shutoff assays to monitor DnaA turnover in wt, lon,

lon, lon ssrA, lon smpB, and lon popA strains. Chloramphenicol was
added to stop synthesis and lysates from samples at the indicated time points
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were used for western blot analysis. Quantifications of duplicate experiments
shown to the right. Error bars represent SD. B. Motility on 0.3% PYE agar of
indicated strains.

Figure 4.7 Characterization of lon PDH. A. Quantification of cell length in wt,

lon, lon PDH cells. B. Antibiotic shutoff assays to monitor DnaA turnover in
wt, lon, lon PDH cells. Chloramphenicol was added to stop synthesis and
lysates from samples at the indicated time points were used for western blot
analysis. Quantifications of triplicate experiments shown to the right. Error bars
represent SD. C. Spot assays of Δlon, wildtype, and lon PDH cells on PYE,
PYE + MMC, PYE + L-canavanine.

177

Chapter 5: Lessons I’ve learned and future perspectives

5.1 Overview
In this chapter I will reflect on the lessons I’ve learned from each chapter in this
thesis as well as explore any remaining future directions.

5.2 ClpX*: Elucidating the mechanisms that govern substrate specificity
In the second chapter of this thesis, I present a mutant of ClpX, ClpX*, which has
gained the ability to degrade Lon substrates in vivo and in vitro. We find this
allows ClpX* to compensate for the absence of Lon, suppressing many lon
defects. We go on to show that this comes at the cost of native ClpXP
substrates, suggesting a cost-benefit to altering substrate specificity. While the
mechanism of how ClpX* could shift substrate specificity eluded us for a long
time, we finally were able to show that ClpX* adopts a more open conformation
than wildtype ClpX and in the process we made a very interesting discovery. We
found that wildtype ClpX could undergo a similar shift in specificity when ATP is
limiting, with similar changes in conformation in these conditions as ClpX*.
This work surprisingly shows us that ATP not only functions as fuel for
AAA+ protease to drive unfolding and translocation but ATP levels can also
dictate substrate specificity. I think our work also shows biochemical
consequences of recently published structures showing open and closed
conformations of these AAA+ proteases (Shin et al. 2021). Although an open
state of ClpX has not been published, our work hints at its existence and
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suggests that the equilibrium between these states has real effects on substrate
choice.
I foresee three major unanswered questions that can be addressed with
future experiments. The first is, while we propose a model where ClpX* shifts the
equilibrium towards the open state of ClpX, how this glycine to alanine mutation
actually does this remains unanswered. Structural studies on the mutant ClpX* in
addition to wildtype ClpX under high and low ATP conditions could provide
insight into the mechanism by which the mutation alters specificity. Additionally, I
wonder if molecular dynamics could be useful in answering this question.
Secondly, how conserved is this idea that altering the dynamic between
conformational states can alter substrate specificity across various AAA+
proteases? While we did not really explore this idea, I think it would be very
interesting to see if limiting ATP for Lon or ClpA has a similar effect to what we
observed for wildtype ClpX. Lastly, we show that DnaA gets degraded faster
under starvation conditions in vivo accompanied by a drop in ATP levels.
However, can we see further evidence of this phenomenon in vivo under other
conditions that deplete ATP.

5.3 Profiling the degradome using a quantitative proteomics approach
In chapter three of this thesis, we present a quantitative proteomics approach we
use to identify potential Lon targets. We go on to profile the degradome of lon
clpX* to identify novel substrates of ClpX*. The point of this work is to present an
approach that can be applicable to various strains and conditions as well as to
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provide the protein degradation community with a resource. We validate that
CcbF is degraded faster by ClpX*, which is evidenced by the increased
resistance to the antibiotic polymyxin B we observed in lon clpX* cells.
Several unanswered questions about this work remain. Firstly, we do not
follow up on the list of potential Lon targets in the paper. Experiments to validate
these candidates as Lon substrates would include deleting these substrates in a

lon and characterizing the mutant. This is important because we’re interested in
Lon substrates that can explain lon defects. Next, follow-up experiments can
include purifying these proteins and testing degradation in vitro. Lastly, validation
efforts should include overexpressing these substrates in a wildtype and
determining if any defects arise.
Additionally, we have had many discussions on the way to go about
defining potential Lon substrates. One of our first iterations involved used the
known Lon substrates, DnaA, CcrM, and SciP to set the lower limits for each
criterion: increased abundance upon Lon deletion, stabilization in a lon, and
decreased abundance upon Lon deletion. However, the issue with this approach
is that only DnaA really shows up as expected for a Lon substrate. While CcrM
levels are more abundant in a lon, we did not observe much faster degradation
in a wildtype compared to a lon. For SciP, we did not see a big difference
between steady state levels in a wildtype and lon, which is consistent with my
work showing that in mixed populations, lon cells do not have elevated SciP
levels. The approach we took in chapter 3 seems more robust than using Lon
substrates to set limits, however, it is not without flaws. For instance, I was
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surprised that there was little overlap between the three criteria we set when
determining Lon substrates. I would expect that there would be good overlap
between the substrates that were more abundant in a lon and substrates that
were stabilized in a lon background.
Lastly, in terms of the discovery of CcbF as a potential ClpX* substrate,
we validate this indirectly using growth curves in the presence of polymyxin B.
However, CcbF was not degraded faster in vitro by ClpX*, suggesting that
perhaps an adaptor is necessary for degradation.

5.4 Suppressor analysis
Chapter 4 is a combination of all the different ways I’ve found over the years that
have suppressed lon defects. Suppressor 25 showed a lot of promise at first
because it suppressed many lon phenotypes, such as morphology and
response to stress. However, many open questions remain, including
determining which mutation is responsible for the phenotypic rescue and
elucidating the mechanism.
An intriguing outcome of this chapter is the link between Lon and
translation which Patrick Cann, an undergraduate in the lab, is actively following
up on. It seems natural that there would be a connection between the pathway
that synthesize proteins and the pathways that degrade proteins. We also have
observed sensitivity of cells lacking Lon to translational inhibitors, such as
tetracycline, and decreased translational efficiency as evidenced by pulse chase
experiments. However, it is not clear how this fits in with data showing the
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translational inhibition is beneficial in a lon. In addition to degrading misfolded
and regulatory proteins, proteases play an important role in recycling amino
acids, with previous work showing that the lethality of proteasome deletion is due
to an amino acid shortage. If this is also the case for Lon remains to be explored.

182

Chapter 6: Appendix

Figure A.1 lon clpX* cells are less resistant to hydroxyurea than lon cells.
These are 10-fold serial dilutions on plates supplemented with the indicated
concentrations of hydroxyurea. This is interesting because we know that lon’s
increased resistance to HU is driven by elevated CcrM levels. However, CcrM
levels remain elevated in lon clpX* cells so I’m not sure why we are seeing a
difference between lon and lon clpX*.
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Figure A.2 Growth curves in the presence of polymyxin B in M5G media. I
backdiluted cells to an OD600 of 0.1 in M5G media, either in full phosphate (10
mM) or low phosphate. All 3 strains are sensitive to polymyxin B under high
phosphate conditions with lon cells being more sensitive than wt and lon
clpX*. We see that growing these cells in low phosphate makes them more
resistant to polymyxin. An interesting hypothesis is that under limiting phosphate
conditions which should deplete ATP levels, wildtype ClpX can now degrade
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CcbF, resulting in increased resistance in lon and wildtype cells. However, we
are also seeing increased resistance to polymyxin in low phosphate conditions in
a lon clpX* background which I would not expect since ClpX* should not
degrade CcbF faster when ATP is limited.
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Figure A.3. Wildtype cells are more resistant to L-canavanine under limiting
phosphate conditions. I backdiluted wildtype to an OD600 of 0.1 in M5G
media, either in 10 mM or 30 uM or 1 uM phosphate.

A.1 Contributions to our understanding of Vibrio Cholera Lon

Figure A.4 C-di-GMP inhibits FITC-Casein degradation by LonA but does
not affect ATP hydrolysis. This is adapted from Figure 6 from (Joshi et al.,
2020). A. FITC-casein degradation assay by purified LonA. B. Initial rate of
substrate degradation as a function of c-di-GMP concentration. C. ATP
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hydrolysis for LonA alone and in the presence of c-di-GMP. D. Rate of ATP
hydrolysis as a function of c-di-GMP concentration.

Figure A.5 Cyclic di-GMP inhibits FITC-casein degradation by Caulobacter
Lon but has no effect on 4E, a DNA-blind mutant. FITC-Casein degradation
assay with Lon and 4E in the absence of cyclic di-GMP and in the presence of
340 uM and 170 uM cyclic di-GMP.

A.2 Purification of VclonA
Grow-up and Induction
o I grew 6 L of cells
o Strain: EPC 1201
o Induction conditions: Grew in LB + AMP until OD was approximately 1.0,
took pre-induction sample
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o Induced with 0.2% arabinose for 3 hours, took post-induction sample
o Spun cells down at 7000 rpm for 8 minutes (I usually do 5000 rpm for 15
minutes)
o Resuspended pellet in lysis buffer (100 mM potassium phosphate at pH
6.5, 1 mM DTT, 1 mM EDTA, 10% glycerol
Hydroxyapatite Batch Binding
o I measured out approximately 5 mls of HA resin into two 50 ml conicals
o Washed once (filling 50 ml conical) with water, spinning at 2000g for 2
mins
o Washed twice with buffer A (100 mM potassium phosphate at pH 6.5, 1
mM DTT, 1 mM EDTA, 10% glycerol), spinning at 2000g for 2 mins
o After lysing cells with microfluidizer, I spun the cells down at 15,000g for
30 minutes.
o I poured off the supernatant and applied it to the prewashed HA resin
o Let batch bind for 30 minutes to 1 hour
*Resin is very pasty, I just take a serological pipette and manually mix it. I
sometimes worry that this is too harsh, but it seems to work out fine.
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Gel after hydroxyapatite batch binding. Loading: Uninduced, induced 1, induced
2, supernatant, pellet, flowthrough, wash 1 (100 mM, wash 2 (100 mM), wash 3
(200 mM), wash 4 (200 mM), E1-E3 (400 mM), and then last three lanes are
larger volume loading.
Washing and Elution
o After batch binding, I spin at 2000g for 10 minutes and collect FT
o Wash with 3CV (15 mls) of buffer A (100 mM potassium phosphate at pH
6.5, 1 mM DTT, 1 mM EDTA, 10% glycerol)
o Again, mix and spin at 2000g for 10 minutes, collect wash
o I did two washes with buffer A (15 mls each) for each 50 ml conical
o Wash with 3CV (15 mls) of buffer B (200 mM potassium phosphate at pH
6.5, 1 mM DTT, 1 mM EDTA, 10% glycerol)
o I did two washes with buffer B (15 mls each) for each 50 ml conical
o Elute with 3X, 1 CV (5 mls) of elution buffer (400 mM potassium
phosphate at pH 6.5, 1 mM DTT, 1 mM EDTA, 10% glycerol)
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o Since I had two 50 ml conicals, I ended up pooling approximately
30 mls of elution
o I filtered the elution using a 0.22 μm and concentrated down to 5 mls using
10 kDA cutoff to run over sephacryl-S200 gel filtration column
S200
o The S200 was equilibrated with 50 mM Tris (pH 8), 1 mM DTT, 1 mM
EDTA, and 20% glycerol.
o Activity assays monitoring FITC-Casein degradation
o 10 ug/ml FITC
o ATP Regeneration Mix
o S200 Fractions with Caulobacter Lon as positive control
Fractions A11 to B11

S200 gel
MonoQ
o MonoQ buffer A: 25 mM Tris pH 8, 50 mM KCl, 10% glycerol, 1 mM DTT
o MonoQ buffer B: 25 mM Tris pH 8, 1M KCl, 20% glycerol, 1 mM DTT
o Activity assays monitoring FITC-Casein degradation
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o 10 ug/ml FITC
o ATP Regeneration Mix
o S200 Fractions with Caulobacter Lon as positive control

Load, A6-B8 Fractions

MonoQ gel 1. Note: This is not Lon!!
Load, B9-C11 Fractions

MonoQ gel 2. Note: this is Lon, so I ran other fractions close to C10 and
C11
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Load, A8-A11, C9-D7 Fractions

MonoQ gel # 3

Load, A8-A11, C9-D7 Fractions

Anti-vclon western blot of the same fraction gel above showing that earlier
fractions are not vcLon.

I pooled fractions C11, C12, D1, and D2 (also had FITC-Casein degradation
activity)
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A.3 Contributions to the Lon degradation project
These figures are adapted from (Barros et al., 2020)

Figure A.6 In vitro degradation assays with Lon and/or ClpAP. (A)(B)
Degradation assays were performed using the native Lon substrate DnaA to test
protease activity, Lon alone, ClpAP with Lon. Reactions consisted of (when
listed) 2.5 µM DnaA, 0.1 µM Lon hexamer, 0.2 µM ClpA, 0.4 µM ClpP. All
reactions contained 4 mM ATP and a regeneration system.
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Figure A.7 The C terminus of Lon is necessary for degradation. (A) Steady-state
protein levels of Lon, DnaA, and ClpP in wt or Δlon strains alone or with Lon,
amino terminus M2-FLAG epitope Lon (M2lon), or carboxy terminus M2-FLAG
epitope Lon (lonM2). Three conditions were tested; − and + were samples grown
overnight under noninducing conditions and then back diluted for outgrowth in
either noninducing (−) or inducing (+) medium. ON samples were grown under
inducing conditions overnight and back diluted under inducing conditions for
outgrowth. In all cases, the outgrowth was done for 6 h. Samples were
normalized to starting OD600 in lysis buffer prior to Western blot analysis.
Cropped images are of Western blots probing for Lon, DnaA, and ClpP.
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Figure A.8. Induction of lonM2 from the xylX promoter shifts cells toward G1
(Adapted from Figure 3D). Strains grown were overnight in the presence of
0.2% xylose or 0.2% glucose and then treated with rifampin for 3 hours. Cells
were fixed and stained with Sytox green before measuring their DNA content by
flow cytometry. Because of the rifampin treatment, cells which have initiated
replication will complete replication, resulting in two distinct peaks of
fluorescence and representing either 1 or 2 chromosomes per cell. The wt cells
are represented by purple, and wt strains containing M2lon or lonM2are in
yellow.
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Figure A.9 Miller assays comparing DnaA’-lacZ expression in wildtype and

clpA cells. A. We found that DnaA’-lacZ was less expressed in clpA cells in
comparison to wildtype cells. B. We noticed a growth-phase specific pattern of
expression where DnaA’-lacZ was more highly expressed in clpA cells in
stationary phase and after 4 hours of outgrowth but expression decreased in

clpA cells after 9 hours of outgrowth, suggesting DnaA’-lacZ expression drops
in clpA.
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A.4 Additional Data

Figure A.10 Depleting DnaA levels in lon is not sufficient to restore
motility or morphology. A. western blot showing DnaA levels in a DnaA
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depletable strain in a lon background. DnaA levels seem to be matched at 0.25
mM IPTG. B. Motility in 0.3% agar. Motility is not restored at any IPTG
concentration suggesting that elevated DnaA levels are not responsible for the
loss of motility in a lon strain. C. Morphology of wildtype and lon and lon plac
DnaA strain at various IPTG concentrations. At high IPTG concentrations which
would lead to high DnaA levels (like a lon), lon plac DnaA are less filamentous
than lon cells. However, this suggests that elevated DnaA levels are not the
sole drivers of filamentation in a lon because then the highest concentrations of
IPTG in lon plac DnaA would be as filamentous as lon.

198

Figure A.11 CtrA is misregulated in a lon. A. Chloramphenicol shutoff
showing DnaA is degraded faster in a lon strain compared to wildtype and lon
clpX*. B. Synchrony in wt, lon, and lon clpX*. lon swarmer (t=0) cells seem to
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have reduced CtrA levels in comparison to wildtype and lon clpX* cells. In
addition, lon cells seem to have delayed CtrA accumulation in comparison to
wildtype cells. C. Steady state levels in swarmer cells. lon cells have reduced
CtrA levels.

Figure A.12 MMC spot assays of wildtype and clpX* cells overexpressing
CtrA and CtrAD51E. These are 10-fold serial dilutions of wildtype and clpX*

200

cells with pVan ctrA and pVan ctrAD51E (phosphomimetic) grown on PYE as a
control and in the presence of MMC.
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Figure A.13 35S-[Cys-Met] Pulse experiments. A. Logarithmically growing
wildtype and lon cells were pulsed for 5 and 10 minutes with [35S]Cys/Met. The cells were lysed and samples were run on an SDS-page gel and
imaged by phosphorimager. Total protein was quantified in each sample. B. The
average of three biological triplicates is shown for the 5-minute pulse, error
bars represent standard deviation. Wildtype (black) has higher
translational efficiency than lon (grey). C. The average of three biological
triplicates is shown for the 10-minute pulse, error bars represent standard
deviation. Wildtype (black) has higher translational efficiency than lon (light
grey) and translational efficiency is restored in lon clpX* (dark grey). D. E. coli

lon cells have lower translational efficiency than wildtype E. coli cells suggesting
that the link between Lon and translation is conserved. These experiments
were graciously completed by Ben Adams from the Hebert lab.

Figure A.14 lon cells are sensitive to tetracycline. Logarithmically growing
wildtype, lon, and lon clpX* (clpXG178A) were normalized by OD600 and 10fold serial dilutions were plated on PYE and PYE tetracycline plates. Wildtype
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and lon are equally viable when grown on PYE. However, lon is more
susceptible to tetracycline in comparison to wildtype and this sensitivity is
suppressed in a lon clpX* strain.

Figure A.15 ClpX* restores pink coloration to lon cells on PYE agarose
supplemented with xylose. A previous study has determined that FixT is a Lon
substrate in Caulobacter (Stein, Fiebig and Crosson, 2020). In our lab, Kethney
Massenat previously showed that deleting FixT in a lon background restores the
pink phenotype. This suggests that ClpX* might degrade FixT faster than
wildtype ClpX which would lower FixT levels in a lon clpX* strain and restore the
pink phenotype.
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Figure A.16 DnaA steady state levels as a function of OD600. The indicated
strains were backdluted to an OD600 of 0.1 in triplicate. Samples were withdrawn
at the indicated OD600s. The samples were lysed and resuspended in 2X SDS
dye. Westerns were probed by anti-DnaA and anti-ClpP antibodies. As expected,
wildtype cells decreased DnaA levels as the OD600 increased which is
consistent with DnaA levels dropping as cells enter stationary phase. We did not
observe this trend for lon cells. However, lon clpX* cells showed a similar
pattern to wildtype cells.
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Figure A.17 Treating cells with uncoupling agent, carbonyl cyanide mchlorophenylhydrazine (CCCP). A-B Wildtype and lon cells were grown in
PYE and backdiluted to an OD600 of 0.1 in PYE or PYE supplemented with
either 1 uM CCCP, 5 uM CCCP, or 10 uM CCCP. We observed that 1 uM CCCP
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did not have an effect on the growth of wildtype or lon cells but we started to
see an impact on growth when using 5 uM CCCP and 10 uM CCCP. C-D.
Wildtype and lon cells were grown in PYE and backdiluted to an OD600 of 0.1
in PYE or PYE supplemented with 1 uM CCCP. Cells treated with 100ug/mL Lcan were treated in liquid culture for an hour before either being backdiluted into
PYE alone or PYE plus 1 uM CCCP. The goal of this experiment is to hit cells
with L-canavanine to create a burst of misfolded proteins and the idea is to
deplete ATP levels with CCCP which should activate ClpX to start degrading
these misfolded proteins so we should observe that cells grown in CCCP + L-can
do better than cells treated with L-can alone. However, we did not see that the Lcan on its own had an effect so this would be worth repeating with various
concentrations of L-canavanine. Although we do see that the CCCP + Lcanavanine cells might be slightly outperforming the L-canavanine alone cells,
this could be also do to the slightly better growth we see with 1 uM CCCP in A
and B. E. Monitoring DnaA degradation in vivo in the presence of CCCP. The
goal of this experiment was to validate our in vitro findings that DnaA is degraded
faster by wildtype ClpX under limiting ATP. However, we observed that 10 uM
CCCP stabilized DnaA in a wt and we still observed some stabilization in the 1
uM CCCP condition. In a lon, when we quantify DnaA degradation, we see that
the 1 uM CCCP also leads to a slight stabilization of DnaA.
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Figure A.18 Morphology in the presence of CCCP. A. lon cells were
backdiluted into PYE and in PYE plus 1 uM CCCP. Cells were imaged in
stationary phase to allow them the opportunity to undergo many doublings. The
purpose of this experiment was to see if addition of CCCP could suppress
filamentation in a lon. However, lon cells grown in the presence of CCCP were
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more filamentous than lon cells in PYE. B. CCCP depletes ATP levels as
measured by the Bactiter Glo assay.
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Figure A.19 Growth curves in the presence of amino acids as a sugar
source. I have previously observed that lon cells grow better in minimal media
supplemented with glucose (see chapter 4). Here instead of using 0.2% glucose,
I supplemented M2 media with different amino acids. In this experiment, we see

lon cells growing better than wildtype in the presence of M2 glutamic acid and
M2 proline.
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Figure A.20 Growth curves in the presence of alternative sugar sources.
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Figure A.21 MG132 inhibits Caulobacter Lon activity in vitro. FITC-Casein
degradation assay in the absence of Lon, presence of Lon, and presence of Lon
and 500 uM MG132.

Figure A.22 The Caulobacter Lon protease is sensitive to ADP inhibition. AC Titrating ADP while keeping ATP constant in TK buffer. Monitoring FITC-
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Casein degradation. D. Plot of initial rate of FITC-Casein degradation as a
function of concentration of ADP (mM). E. Titrating ADP while keeping ATP
constant in Sucrose buffer. E. Plot of initial rate of FITC-Casein degradation as a
function of concentration of ADP (mM) in sucrose buffer. Lon is less susceptible
to ADP inhibition in sucrose buffer.

A.5 AHA labeling and Click Chemistry Protocol
Pulsing cells with AHA
1) Resuspend AHA probe in DMSO
- 100 mg in 1 mL DMSO so stock is 100 mg/mL or 554 mM
- Store aliquots at -20 degree Celsius
2) Grow cells to mid exponential phase in M2G
3) Dilute AHA probe 1:1000 into cells so 0.55mM final so added 20ul to 20 mL
cultures and let it incubate for 60 minutes
4) Spun down AHA-treated cells at 6000g for 5 minutes then washed three times
in cold Phosphate BS.
5) Freeze pellets at -80 °C until ready for next steps
6) Thaw AHA-labeled cells and resuspend in lysis buffer (50 mM Tris-HCl pH 8.0,
5% glycerol, 0.5% SDS, 1 mM PMSF).
7) Sonicate
- 40 Amplitude
- 10 second pulses for 1 minute
- After every 10 second pulse, put back on ice briefly
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8) Spin to clear lysate at max speed at 4 °C for 20 minutes
9) Transfer supernatant to new tube
Copper Catalyzed Rxn
Reagents
CuSO4: Made 50 mM stock in water (make fresh)
Sodium ascorbate: 12mg/mL stock in water (60.6 uM) (make fresh)
AF 488 Alkyne: 1 mg/mL in water (1.3mM) (stored aliquots at -20 °C)
TBTA (borrowed from Hebert lab, they make it at 25mg/mL in DMSO and store at
-20°C)

1) Had 500 ul lysate from each strain
2) Added the following in this order:
10 ul CuSO4 (1mM final)
10 ul Sodium Ascorbate (final 1.2 mM)
20 ul fluorphore (Final 50 uM)
1.36 ul TBTA (Final 128 uM)
3) Incubate covered in foil for 30 minutes
Methanol chloroform extraction
1)) Add 1800 ul methanol and vortex briefly
2) Add 450 ul chloroform and vortex briefly
3) Add 1200 ul water, becomes cloudy
4) Centrifuge at 14,000 g for 5 mins
5) Remove upper aqueous layer (was bright green)
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6) Add 1350 ul methanol
7) Spin again at 14,000 g for 5 mins
8) Remove liquid and add 1350 ul of methanol again
9) Spin at 14,000 g for 5 mins
10) Remove supernatant and let pellet dry with cap off for 15 mins
11) Store pellet at -20 °C
Running SDS-PAGE gel
1) Resuspend pellet in 2X SDS dye
I first resuspend in water and took a Bradford measurement to normalize
protein input? Then added 5X SDS dye to dilute to 2X
2) Heat at 65 °C for 10 mins (covered in foil)
3) Spin at max speed for 10 mins
4) Load samples on gel and run gel in the dark (can cover with Styrofoam
container)
5) Put gel in water and cover with aluminum foil
6) Image with Typhoon
o Use software on Typhoon computer for analysis
o Image quant, 1D gel analysis
o Automatic, rolling ball
o Set radius to 100
o Click once and drag to quantify total lane
7) Can stain with Coomassie after to make sure protein loading is the same
Controls to include:
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- AHA, - click
- AHA, + click
+ AHA, - click
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